image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
9722bcc8fa60e40e09b985bb7174652931bd78de061db8c6edab563ba26d149c.png | complex | <table><tr><td> </td><td colspan="3">Intracerebral hemorrhage</td><td colspan="3">Ischemic stroke</td></tr><tr><td> </td><td>mRS ≤2* (n = 23)</td><td>mRS > 2 (n = 20)</td><td><i>P</i></td><td>mRS ≤2* (n = 82)</td><td>mRS > 2 (n = 81)</td><td><i>P</i></td></tr><tr><td>Age (years)</td><td>54.2 ± 12... | <table><tr><td></td><td colspan="3">Intracerebral hemorrhage</td><td colspan="3">Ischemic stroke</td></tr><tr><td></td><td>mRS ≤2* (n = 23)</td><td>mRS > 2 (n = 20)</td><td>P</td><td>mRS ≤2* (n = 82)</td><td>mRS > 2 (n = 81)</td><td>P</td></tr><tr><td>Age (years)</td><td>54.2 ± 12.9</td><td>66.8 ± 13.9</td><td>0.004</t... | <table><tr><td>Hypertension</td><td>21 (91.3)</td><td>18 (90.0)</td><td>1.000</td><td>53 (64.6)</td><td>66 (81.5)</td><td>0.021</td></tr><tr><td>Hyperlipidemia</td><td>3 (13.0)</td><td>6 (30.0)</td><td>0.263</td><td>25 (30.5)</td><td>28 (34.6)</td><td>0.618</td></tr><tr><td>Atril fibrillation</td><td>1 (4.3)</td><td>1 ... |
f1a414cfb21bcb80ca0ca418afe7435b13966e6a0efb14c0458214372796b883.png | complex | <table><tr><td></td><td colspan="3">Level of BCPO<sup>d</sup> (%)</td><td></td><td colspan="3"><i>P</i> value</td></tr><tr><td>Parameter</td><td>0</td><td>4</td><td>8</td><td>SEM</td><td>Overall</td><td>Linear</td><td>Quadratic</td></tr><tr><td>C14:0, myristic</td><td>6.67<sup>a</sup></td><td>5.70<sup>b</sup></td><td>5... | <table><tr><td></td><td colspan="3">Level of BCPOd (%)</td><td></td><td colspan="3">P value</td></tr><tr><td>Parameter</td><td>0</td><td>4</td><td>8</td><td>SEM</td><td>Overall</td><td>Linear</td><td>Quadratic</td></tr><tr><td>C14:0, myristic</td><td>6.67a</td><td>5.70b</td><td>5.04c</td><td>0.53</td><td>0.048</td><td>... | <table><tr><td>16</td><td>.42</td><td>11.28</td><td>0.12</td><td></td><td>1</td><td>8</td><td>1</td></tr><tr><td>ID18</td><td>43.35</td><td>42.88</td><td>51.85</td><td>2.99</td><td>0.612</td><td>0.234</td><td>0.516</td></tr><tr><td>Elongation Index (EI)</td><td>60.13</td><td>59.74</td><td>65.29</td><td>3.03</td><td>0.8... |
6068031b53b8d4da48253ae184228a6d325426177cffe51c881e86246b665bd5.png | complex | <table><tr><td>Items</td><td>MS1 T1</td><td>M2 T1</td><td><i>p</i></td><td>Ms1 T2</td><td>MS2 T2</td><td><i>p</i></td><td>MS3 T3</td><td>MS4 T3</td><td><i>p</i></td></tr><tr><td colspan="10">How important are the following factors in considering your career in medicine?</td></tr><tr><td>Opportunities to make a differen... | <table><tr><td>Items</td><td>MS1 T1</td><td>M2 T1</td><td>p</td></tr><tr><td colspan="4">How important are the following factors in considering your career in medicine?</td></tr><tr><td>Opportunities to make a difference in people’s lives</td><td>4.89</td><td>4.83</td><td>NS</td></tr><tr><td>Intellectual climate</td><t... | <table><tr><td>Ms1 T2</td><td>MS2 T2</td><td>p</td><td>MS3 T3</td><td>MS4 T3</td><td>p</td></tr><tr><td colspan="6">How important are the following factors in considering your career in medicine?</td></tr><tr><td>4.88</td><td>4.83</td><td>NS</td><td>4.71</td><td>4.66</td><td>NS</td></tr><tr><td>4.41</td><td>4.47</td><t... |
61ddb634f850303156938c68d65a5cd676357a3f1df3c68b1f44b91763fc4c32.png | complex | <table><tr><td>Stigma</td><td colspan="4">Medication adherence</td><td>Total</td><td>Statistics</td></tr><tr><td></td><td colspan="2">Non adherent</td><td colspan="2">Adherent</td><td></td><td></td></tr><tr><td></td><td><i>f</i></td><td>%</td><td><i>f</i></td><td>%</td><td></td><td></td></tr><tr><td>No perceived stigma... | <table><tr><td>Stigma</td><td colspan="4">Medication adherence</td><td>Total</td><td>Statistics</td></tr><tr><td></td><td colspan="2">Non adherent</td><td colspan="2">Adherent</td><td></td><td></td></tr><tr><td></td><td>f</td><td>%</td><td>f</td><td>%</td><td></td><td></td></tr><tr><td>No perceived stigma</td><td>8</td... | <table><tr><td>Total</td><td>15</td><td>10.6</td><td>126</td><td>89.4</td><td>141</td><td>-</td></tr></table> |
7f0242ff918556966d026c12303533cca03d61913e2eba5df07f81fa03bdc2bc.png | complex | <table><tr><td>Model</td><td>Parameters</td><td>True value</td><td>Mean estimation</td><td>Estimated error</td></tr><tr><td colspan="5">Three-way model</td></tr><tr><td>Case I</td><td>G-C/M-C/M-G</td><td>0.2</td><td>0.23</td><td>0.04</td></tr><tr><td>Case II</td><td>G-C/M-C/M-G</td><td>0.3</td><td>0.31</td><td>0.05</td... | <table><tr><td>Model</td><td>Parameters</td><td>True value</td><td>Mean estimation</td><td>Estimated error</td></tr><tr><td colspan="5">Three-way model</td></tr><tr><td>Case I</td><td>G-C/M-C/M-G</td><td>0.2</td><td>0.23</td><td>0.04</td></tr><tr><td>Case II</td><td>G-C/M-C/M-G</td><td>0.3</td><td>0.31</td><td>0.05</td... | <table><tr><td colspan="5">Independent model</td></tr><tr><td>Case I</td><td>G-C/M-C</td><td>0.2</td><td>0.22</td><td>0.04</td></tr><tr><td>Case II</td><td>G-C/M-C</td><td>0.3</td><td>0.31</td><td>0.05</td></tr><tr><td>Case III</td><td>G-C/M-C</td><td>0.4</td><td>0.43</td><td>0.04</td></tr><tr><td>Causal model</td><td>... |
60f181fc7f61bf64fb9bb25840e94a83f1e30babde182ff110da4db543064cb5.png | complex | <table><tr><td></td><td>Univariate OR (95 % CI)<sup>a</sup></td><td><i>p</i> value<sup>b</sup></td><td>Multivariate aOR (95 % CI)</td><td><i>p</i> value</td></tr><tr><td colspan="5">Sociodemographic</td></tr><tr><td> Intercept</td><td>–</td><td>–</td><td>4.78 (0.98, 23.41)</td><td>0.054</td></tr><tr><td> Ag... | <table><tr><td></td><td>Univariate OR (95 % CI)a</td></tr><tr><td colspan="2">Sociodemographic</td></tr><tr><td>Intercept</td><td>–</td></tr><tr><td>Age: per 5-year increase</td><td>0.85 (0.77, 0.94)</td></tr><tr><td>Male</td><td>1.58 (1.07, 2.31)</td></tr><tr><td>Born in Canada</td><td>1.09 (0.62, 1.91)</td></tr><tr><... | <table><tr><td>p valueb</td><td>Multivariate aOR (95 % CI)</td><td>p value</td></tr><tr><td colspan="3">Sociodemographic</td></tr><tr><td>–</td><td>4.78 (0.98, 23.41)</td><td>0.054</td></tr><tr><td><0.001</td><td>0.90 (0.81, 1.00)</td><td>0.057</td></tr><tr><td>0.020</td><td>1.26 (0.78, 2.04)</td><td>0.343</td></tr><tr... |
09d00b5a7cdc1c3a549329771e937315bca57695175a90435d43d5c9875a111f.png | complex | <table><tr><td rowspan="2">Participant</td><td rowspan="2">TTD (Months)</td><td rowspan="2">FIGO stage</td><td colspan="9">First attributions of illness symptoms</td></tr><tr><td>Retained condom</td><td>Intestinal worms</td><td>Genital infections (syphilis, gonorrhoea and Candida)</td><td>Menstrual problems (Menopause ... | <table><tr><td rowspan="2">Participant</td><td rowspan="2">TTD (Months)</td><td rowspan="2">FIGO stage</td><td colspan="6">First attributions of illness symptoms</td></tr><tr><td>Retained condom</td><td>Intestinal worms</td><td>Genital infections (syphilis, gonorrhoea and Candida)</td><td>Menstrual problems (Menopause ... | <table><tr><td colspan="3">First attributions of illness symptoms</td></tr><tr><td>HIV and/or its complications</td><td>Cervical cancer</td><td>Other serious illness</td></tr><tr><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td></tr><... |
5f99058a5c95d9a99115fa18cbb759703ad3bcc3a1d93e455e19a37402fd4265.png | complex | <table><tr><td rowspan="2"></td><td colspan="5">PI-RADS v2 score</td></tr><tr><td>1<i>n</i> = 22</td><td>2<i>n</i> = 11</td><td>3<i>n</i> = 55</td><td>4<i>n</i> = 97</td><td>5<i>n</i> = 30</td></tr><tr><td>Insignificant PCa, n (%)</td><td>3 (13.6%)</td><td>0 (0%)</td><td>2 (3.6%)</td><td>12 (12.4%)</td><td>1 (3.3%)</td... | <table><tr><td></td><td colspan="5">PI-R</td></tr></table> | <table><tr><td rowspan="2"></td><td colspan="5">ADS v2 score</td></tr><tr><td>1n = 22</td><td>2n = 11</td><td>3n = 55</td><td>4n = 97</td><td>5n = 30</td></tr><tr><td>Insignificant PCa, n (%)</td><td>3 (13.6%)</td><td>0 (0%)</td><td>2 (3.6%)</td><td>12 (12.4%)</td><td>1 (3.3%)</td></tr><tr><td>Significant PCa, n (%)</t... |
12d852f872368f6a22550a793d2612a6d92a222735dc6b95b999c65ce5bf05a2.png | simple | <table><tr><td>GeneID</td><td>Product Name</td><td>Locus</td><td>AMX*</td><td>CTC*</td><td>ENR*</td></tr><tr><td>1244239</td><td>ImpA</td><td>impA</td><td>-0.52</td><td>-0.53</td><td>4.55</td></tr><tr><td>1244433</td><td>DNA-binding protein Fis</td><td>fis</td><td>ns</td><td>ns</td><td>1.41</td></tr><tr><td>1244528</td... | <table><tr><td>GeneID</td><td>Product Name</td><td>Locus</td><td>AMX*</td><td>CTC*</td><td>ENR*</td></tr><tr><td>1244239</td><td>ImpA</td><td>impA</td><td>-0.52</td><td>-0.53</td><td>4.55</td></tr><tr><td>1244433</td><td>DNA-binding protein Fis</td><td>fis</td><td>ns</td><td>ns</td><td>1.41</td></tr><tr><td>1244528</td... | <table><tr><td>GeneID</td><td>Product Name</td><td>Locus</td><td>AMX*</td><td>CTC*</td><td>ENR*</td></tr><tr><td>1244823</td><td>DNA gyrase subunit B</td><td>gyrB</td><td>ns</td><td>1.36</td><td>1.45</td></tr><tr><td>1245063</td><td>NAD-dependent DNA ligase LigA</td><td>ligA</td><td>-0.84</td><td>1.08</td><td>1.56</td>... |
ca8e02af11c49ec6fa1b7f988e725671947b556882217599e3e8c89f9ea63dc8.png | simple | <table><tr><td>Variable</td><td>Average interitem covariance</td><td>Number of items in the scale</td><td>Scale reliability coefficient</td></tr><tr><td>Distance</td><td>0.448</td><td>6</td><td>0.748</td></tr><tr><td>Positive</td><td>0.309</td><td>3</td><td>0.563</td></tr><tr><td>Demands</td><td>1.024</td><td>4</td><td... | <table><tr><td>Variable</td><td>Average interitem covariance</td><td>Number of items in the scale</td></tr><tr><td>Distance</td><td>0.448</td><td>6</td></tr><tr><td>Positive</td><td>0.309</td><td>3</td></tr><tr><td>Demands</td><td>1.024</td><td>4</td></tr></table> | <table><tr><td>Scale reliability coefficient</td></tr><tr><td>0.748</td></tr><tr><td>0.563</td></tr><tr><td>0.852</td></tr></table> |
ed436587e2b5cbe28eb97709387e8ba8b0e05011c68006fdc24a410493d6144f.png | simple | <table><tr><td>Fragment</td><td>Size (bp)</td><td>Primer sequences (5'-3')</td></tr><tr><td>NC1</td><td>2573</td><td>FP: GATCCTGGGCCCCACATCCATCCTC</td></tr><tr><td></td><td></td><td>RP: GATCGAATTCGCCCGGGAGGCCAGGGTCG</td></tr><tr><td>NC2</td><td>524</td><td>FP: GATCGAATTCGGCGAGAAGGGAGAAGCTGC</td></tr><tr><td></td><td></... | <table><tr><td>Fragment</td><td>Size (bp)</td></tr><tr><td>NC1</td><td>2573</td></tr><tr><td></td><td></td></tr><tr><td>NC2</td><td>524</td></tr><tr><td></td><td></td></tr></table> | <table><tr><td>Primer sequences (5'-3')</td></tr><tr><td>FP: GATCCTGGGCCCCACATCCATCCTC</td></tr><tr><td>RP: GATCGAATTCGCCCGGGAGGCCAGGGTCG</td></tr><tr><td>FP: GATCGAATTCGGCGAGAAGGGAGAAGCTGC</td></tr><tr><td>RP: GATCAAGCTTTCAGTCCTGGGCAGTACCTGT</td></tr></table> |
c77344b3b4cf4404f6c181a605e73981b0f752fd8faf3ff64971d59e6e9e2c42.png | simple | <table><tr><td>Heavy Metal</td><td>Arsenic (47)</td><td>Cadmium (34)</td><td>Mercury (30)</td><td>Lead (29)</td></tr><tr><td>Year</td><td>2012 (16), 2011 (16)</td><td>2009 (4), 2013 (4), 2014 (4)</td><td>2016 (9), 2013 (5), 2015 (5)</td><td>2016 (5), 2002 (4), 2006 (3), 2013 (3)</td></tr><tr><td>Product category</td><t... | <table><tr><td>Heavy Metal</td></tr><tr><td>Year</td></tr><tr><td>Product category</td></tr><tr><td>Notifying country</td></tr><tr><td>Origin country</td></tr><tr><td>Notification basis</td></tr><tr><td>Notification type</td></tr><tr><td>Distribution status</td></tr><tr><td>Risk decision</td></tr><tr><td>Action taken</... | <table><tr><td>Arsenic (47)</td><td>Cadmium (34)</td><td>Mercury (30)</td><td>Lead (29)</td></tr><tr><td>2012 (16), 2011 (16)</td><td>2009 (4), 2013 (4), 2014 (4)</td><td>2016 (9), 2013 (5), 2015 (5)</td><td>2016 (5), 2002 (4), 2006 (3), 2013 (3)</td></tr><tr><td>feed materials (18), pet food (12)</td><td>feed additive... |
e37d12121abb7744b1945deb9be18afa5cb6ba2689c1c2296910407be48a8670.png | complex | <table><tr><td>Location</td><td></td><td colspan="4">Annual average hourly NO<sub>2 </sub>(μg/m<sup>3</sup>) based on the LUR estimate</td></tr><tr><td></td><td>percent</td><td>min</td><td>max</td><td>mean</td><td>sd</td></tr><tr><td>Residences</td><td>100</td><td>6</td><td>56</td><td>28</td><td>8</td></tr><tr><td... | <table><tr><td>Location</td><td></td><td colspan="4">Annual average hourly NO2 (μg/m3) based on the LUR estimate</td></tr><tr><td></td><td>percent</td><td>min</td><td>max</td><td>mean</td><td>sd</td></tr></table> | <table><tr><td>Residences</td><td>100</td><td>6</td><td>56</td><td>28</td><td>8</td></tr><tr><td>freeway/highway/arterial/ramp</td><td>17</td><td>15</td><td>56</td><td>34</td><td>9</td></tr><tr><td>Collector</td><td>17</td><td>2</td><td>56</td><td>26</td><td>8</td></tr><tr><td>local/strata/lane</td><td>66</td><td>2</td... |
927afc4a00e697099cc4ef7f43147612b6b0056f5f74aa275579a38924566e2e.png | complex | <table><tr><td>Name</td><td>First protein</td><td>Second protein</td><td colspan="3">Sequence of the fusion helix</td></tr><tr><td>3,305</td><td>Protein A</td><td>mbp3–16</td><td>266*</td><td>QCAREAAREAAACD</td><td>13*</td></tr><tr><td>3,306</td><td>mbp3–16</td><td>Protein A</td><td>133</td><td>QCAREAAAREAA... | <table><tr><td>Name</td><td>First protein</td><td>Second protein</td><td colspan="3">Sequence of the fusion helix</td></tr><tr><td>3,305</td><td>Protein A</td><td>mbp3–16</td><td>266*</td><td>QCAREAAREAAACD</td><td>13*</td></tr><tr><td>3,306</td><td>mbp3–16</td><td>Protein A</td><td>133</td><td>QCAREAAAREAACN</td><td>2... | <table><tr><td>Name</td><td>First protein</td><td>Second protein</td><td colspan="3">Sequence of the fusion helix</td></tr><tr><td>4,256</td><td>Protein A</td><td>mbp3–16</td><td>260</td><td>KCLNDAQAAKLLCA</td><td>21</td></tr><tr><td>4,257</td><td>Protein A</td><td>mbp3–16</td><td>259</td><td>ACKLNAAQALGRCL</td><td>18<... |
a9c0d3b016e9ea0c408eeb190b5ca5c6e254283014ff2fcade21354a1bd59422.png | complex | <table><tr><td></td><td colspan="3">Number of filled prescriptions</td><td colspan="6">Switching between different statins</td></tr><tr><td></td><td colspan="3"><i>≥ 2 filled statin prescriptions</i></td><td colspan="3"><i>No switches</i></td><td colspan="3"><i>1-3 switches</i></td></tr><tr><td></td><td>N</td><td... | <table><tr><td></td><td colspan="3">Number of filled prescriptions</td><td colspan="6">Switching between different statins</td></tr><tr><td></td><td colspan="3">≥ 2 filled statin prescriptions</td><td colspan="3">No switches</td><td colspan="3">1-3 switches</td></tr><tr><td></td><td>N</td><td>Mean (%)</td><td>95% CI</t... | <table><tr><td></td><td colspan="3">Number of filled prescriptions</td><td colspan="6">Switching between different statins</td></tr><tr><td></td><td colspan="3">≥ 2 filled statin prescriptions</td><td colspan="3">No switches</td><td colspan="3">1-3 switches</td></tr><tr><td></td><td>N</td><td>Mean (%)</td><td>95% CI</t... |
a79b4b846bf20389144f463aadda3e274ad03ea5287a50ef01a88d73dc3390a3.png | simple | <table><tr><td>Methylation probe</td><td>Distance from <i>MEG3</i> TSS</td><td>Correlation with 14q32 prognostic miRNAs</td><td>Number of miRNAs</td><td>Overlap with CTCF binding site</td></tr><tr><td>cg1656</td><td>1326</td><td>None</td><td>None</td><td>Near site (in promoter)</td></tr><tr><td>cg0928</td><td>775</td><... | <table><tr><td>Methylation probe</td><td>Distance from MEG3 TSS</td><td>Correlation with 14q32 prognostic miRNAs</td><td>Number of miRNAs</td><td>Overlap with CTCF binding site</td></tr><tr><td>cg1656</td><td>1326</td><td>None</td><td>None</td><td>Near site (in promoter)</td></tr><tr><td>cg0928</td><td>775</td><td>0.46... | <table><tr><td>Methylation probe</td><td>Distance from MEG3 TSS</td><td>Correlation with 14q32 prognostic miRNAs</td><td>Number of miRNAs</td><td>Overlap with CTCF binding site</td></tr><tr><td>cg1510</td><td>−1264</td><td>0.546 (0.621 to 0.428)</td><td>2</td><td>Near site (within gene body)</td></tr><tr><td>cg0429</td... |
d961a82d35e77ad98acbf39025cdbb7a0ab75b97b5ba4fd479da7f4cf9ce9a2b.png | complex | <table><tr><td rowspan="2">tRF5</td><td rowspan="2">Anticodon</td><td colspan="2">ELISA status</td><td rowspan="2">SE</td><td rowspan="2"><i>P</i>-value</td></tr><tr><td>Negative (RPM)<sup>a</sup></td><td>Positive (RPM)<sup>a</sup></td></tr><tr><td>tRF5-Ala</td><td>CGC</td><td>616</td><td>494</td><td>31</td><td>0.0081<... | <table><tr><td rowspan="2">tRF5</td><td rowspan="2">Anticodon</td><td colspan="2">ELISA status</td><td rowspan="2">SE</td><td rowspan="2">P-value</td></tr><tr><td>Negative (RPM)a</td><td>Positive (RPM)a</td></tr><tr><td>tRF5-Ala</td><td>CGC</td><td>616</td><td>494</td><td>31</td><td>0.0081</td></tr><tr><td>tRF5-Glu</td... | <table><tr><td rowspan="2">tRF5</td><td rowspan="2">Anticodon</td><td colspan="2">ELISA status</td><td rowspan="2">SE</td><td rowspan="2">P-value</td></tr><tr><td>Negative (RPM)a</td><td>Positive (RPM)a</td></tr><tr><td>tRF5-Lys</td><td>CTT</td><td>3800</td><td>6933</td><td>534</td><td>0.0002</td></tr><tr><td>tRF5-Lys<... |
d57c0be74e03f3c0fd578058963cc498cf7c917e511abd543a9f0431433ac0c6.png | complex | <table><tr><td>Variable</td><td>non-MetS</td><td>MetS</td><td>Entire sample</td><td>p value*</td></tr><tr><td colspan="5"><i>Demographical information</i></td></tr><tr><td>N</td><td>1194</td><td>783</td><td>1977</td><td></td></tr><tr><td>Age years</td><td>59.8 ± 8.85</td><td>61.56 ± 8.37</td><td>60.5 ± 8... | <table><tr><td>Variable</td><td>non-MetS</td><td>MetS</td><td>Entire sample</td><td>p value*</td></tr><tr><td colspan="5">Demographical information</td></tr><tr><td>N</td><td>1194</td><td>783</td><td>1977</td><td></td></tr><tr><td>Age years</td><td>59.8 ± 8.85</td><td>61.56 ± 8.37</td><td>60.5 ± 8.71</td><td><0.001</td... | <table><tr><td>Variable</td><td>non-MetS</td><td>MetS</td><td>Entire sample</td><td>p value*</td></tr><tr><td>Weight kg</td><td>60.41 ± 9.78</td><td>67.69 ± 10.5</td><td>63.3 ± 10.68</td><td><0.001</td></tr><tr><td>SBP mmHg</td><td>122.61 ± 17.33</td><td>135.52 ± 18.34</td><td>127.71 ± 18.82</td><td><0.001</td></tr><tr... |
75d4c9794a55e3bc3f1f940b144934300158645eb8689767594bb084bfe333db.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Multivariate analysis (DFS)</td><td colspan="2">Multivariate analysis (OS)</td></tr><tr><td><i>P</i>-value</td><td>HR (95%CI)</td><td><i>P</i>-value</td><td>HR (95%CI)</td></tr><tr><td>AJCC stage (I/II vs. III/IV)</td><td>0.037*</td><td>2.621 (1.011–6.668)</... | <table><tr><td>Variable</td><td colspan="2">Multivariate analysis (DFS)</td><td colspan="2">Multivariate analysis (OS)</td></tr></table> | <table><tr><td>Variable</td><td>P-value</td><td>HR (95%CI)</td><td>P-value</td><td>HR (95%CI)</td></tr><tr><td>AJCC stage (I/II vs. III/IV)</td><td>0.037*</td><td>2.621 (1.011–6.668)</td><td>0.029*</td><td>2.915 (1.113–7.634)</td></tr><tr><td>N stage (N0 vs. N1 + N2)</td><td>0.043*</td><td>2.354 (1.027–5.395)</td><td>0... |
ebde2c998d2b109b052c444bf1c4ed63f5923f839073d747a7285ca8919edc47.png | simple | <table><tr><td></td><td>Patient 1</td><td>Patient 2</td><td>Patient 3</td><td>Patient 4</td></tr><tr><td>First time TB diagnosis</td><td>1995</td><td>1992</td><td>1985</td><td>2001</td></tr><tr><td>Immigration Date</td><td>August-97</td><td>July-97</td><td>March-92</td><td>March-03</td></tr><tr><td>Duration between TB ... | <table><tr><td></td><td>Patient 1</td><td>Patient 2</td><td>Patient 3</td><td>Patient 4</td></tr><tr><td>First time TB diagnosis</td><td>1995</td><td>1992</td><td>1985</td><td>2001</td></tr><tr><td>Immigration Date</td><td>August-97</td><td>July-97</td><td>March-92</td><td>March-03</td></tr><tr><td>Duration between TB ... | <table><tr><td></td><td>Patient 1</td><td>Patient 2</td><td>Patient 3</td><td>Patient 4</td></tr><tr><td>Duration between MDR TB and XDR TB diagnosis</td><td>2 years</td><td>5 years</td><td>1.3 years</td><td>concurrent</td></tr><tr><td>Duration between XDR TB diagnosis and end of antituberculous drug therapy in Germany... |
c3f3037d5eb812cb70de4c21f3b5123aa14641517f1142a5c43a091096ad2845.png | simple | <table><tr><td></td><td>p-value</td></tr><tr><td>MicroRNA</td><td>(Hypoxia vs Normoxia)</td></tr><tr><td>ambi_miR_8488</td><td>0.00038</td></tr><tr><td>hsa_miR_152</td><td>0.00064</td></tr><tr><td>ambi_miR_13232</td><td>0.00137</td></tr><tr><td>hsa_miR_193b</td><td>0.00161</td></tr><tr><td>hsa_miR_26a</td><td>0.00204</... | <table><tr><td></td><td>p-value</td></tr><tr><td>MicroRNA</td><td>(Hypoxia vs Normoxia)</td></tr><tr><td>ambi_miR_8488</td><td>0.00038</td></tr><tr><td>hsa_miR_152</td><td>0.00064</td></tr><tr><td>ambi_miR_13232</td><td>0.00137</td></tr><tr><td>hsa_miR_193b</td><td>0.00161</td></tr><tr><td>hsa_miR_26a</td><td>0.00204</... | <table><tr><td></td><td>p-value</td></tr><tr><td>MicroRNA</td><td>(Hypoxia vs Normoxia)</td></tr><tr><td>hsa_miR_206</td><td>0.04786</td></tr></table> |
07042467c60a195c6869a677371bd6d024c682bf79ecb22adcac2a88971f1b04.png | simple | <table><tr><td>DHA source</td><td>Frequency, n</td></tr><tr><td>Salmon</td><td>6</td></tr><tr><td>Herring</td><td>5</td></tr><tr><td>Tuna</td><td>4</td></tr><tr><td>Cod</td><td>3</td></tr><tr><td>Brook trout</td><td>3</td></tr><tr><td>Trout</td><td>2</td></tr><tr><td>Carp</td><td>1</td></tr><tr><td>Sardines</td><td>1</... | <table><tr><td>DHA source</td><td>Frequency, n</td></tr><tr><td>Salmon</td><td>6</td></tr><tr><td>Herring</td><td>5</td></tr><tr><td>Tuna</td><td>4</td></tr><tr><td>Cod</td><td>3</td></tr><tr><td>Brook trout</td><td>3</td></tr><tr><td>Trout</td><td>2</td></tr><tr><td>Carp</td><td>1</td></tr><tr><td>Sardines</td><td>1</... | <table><tr><td>Caviar</td><td>1</td></tr></table> |
8c7a165ecb7c7ad95aa6860e25844e8e456fd274b8c57f9c295484f48f312d14.png | simple | <table><tr><td>Site</td><td>MPM</td><td>AF</td><td>BU</td><td>HE</td><td>HY</td><td>LE</td><td>RA</td><td>XE</td><td>Unk</td></tr><tr><td>Djorse</td><td>Pos</td><td>12</td><td>10</td><td></td><td></td><td></td><td>4</td><td></td><td></td></tr><tr><td>Otuaplem</td><td>Pos</td><td>4</td><td></td><td>10</td><td></td><td>1... | <table><tr><td>Site</td><td>MPM</td></tr><tr><td>Djorse</td><td>Pos</td></tr><tr><td>Otuaplem</td><td>Pos</td></tr><tr><td>Sarpeiman</td><td>Pos</td></tr><tr><td>Seduase</td><td>Pos</td></tr><tr><td>Achiaman</td><td>Pos</td></tr><tr><td>Kwashikuma</td><td>Pos</td></tr><tr><td>Weija</td><td>Pos</td></tr></table> | <table><tr><td>AF</td><td>BU</td><td>HE</td><td>HY</td><td>LE</td><td>RA</td><td>XE</td><td>Unk</td></tr><tr><td>12</td><td>10</td><td></td><td></td><td></td><td>4</td><td></td><td></td></tr><tr><td>4</td><td></td><td>10</td><td></td><td>1</td><td>2</td><td>12</td><td></td></tr><tr><td>1</td><td>13</td><td></td><td>8</... |
e7bc9588165c9745e0e744c596f5e4759d482ccc867bf182aa14d99fbe767527.png | simple | <table><tr><td>Cigarette</td><td>Erg %</td><td>LPS %</td></tr><tr><td>Newport Menthol</td><td>4.45</td><td>3.36</td></tr><tr><td>Camel Turkish Royal</td><td>9.90</td><td>6.18</td></tr><tr><td>Pall Mall</td><td>13.3</td><td>6.01</td></tr><tr><td>Kool</td><td>9.30</td><td>4.26</td></tr><tr><td>Parliament Lights</td><td>1... | <table><tr><td>Cigarette</td><td>Erg %</td><td>LPS %</td></tr><tr><td>Newport Menthol</td><td>4.45</td><td>3.36</td></tr><tr><td>Camel Turkish Royal</td><td>9.90</td><td>6.18</td></tr></table> | <table><tr><td>Pall Mall</td><td>13.3</td><td>6.01</td></tr><tr><td>Kool</td><td>9.30</td><td>4.26</td></tr><tr><td>Parliament Lights</td><td>10.00</td><td>3.00</td></tr><tr><td>Liggett Select Full Flavor</td><td>8.57</td><td>3.99</td></tr><tr><td>University of Kentucky</td><td>10.86</td><td>6.30</td></tr></table> |
169cc4ee0226214a346997cd4ef405ac0b79bce6299df79fa9a266a0bc34dddb.png | simple | <table><tr><td>Trait</td><td>Reference</td></tr><tr><td>Agronomic traits</td></tr><tr><td>Yield and yield parameters</td><td>Nath and Alam (2002)</td></tr><tr><td>Pod characters</td><td>Swamy et al. (2006)</td></tr><tr><td>Seed dormancy</td><td>Wang et al. (2012)</td></tr><tr><td>Early maturity</td><td>Upadhyaya et al.... | <table><tr><td>Trait</td></tr><tr><td>Agronomic traits</td></tr><tr><td>Yield and yield parameters</td></tr><tr><td>Pod characters</td></tr><tr><td>Seed dormancy</td></tr><tr><td>Early maturity</td></tr><tr><td>Resistance to diseases and insect pests</td></tr><tr><td>Early leaf spot (Cercospora arachidicola Hori)</td><... | <table><tr><td>Reference</td></tr><tr><td></td></tr><tr><td>Nath and Alam (2002)</td></tr><tr><td>Swamy et al. (2006)</td></tr><tr><td>Wang et al. (2012)</td></tr><tr><td>Upadhyaya et al. (2006)</td></tr><tr><td></td></tr><tr><td>Singh et al. (1997), Holbrook and Isleib (2001)</td></tr><tr><td>Singh et al. (1997, 2003)... |
372340f9773360aff7ef8edfe00ed9d82722a9455d98a23fc48e4c71dadc6e6f.png | complex | <table><tr><td>Clinical data</td><td colspan="2">Dengue</td><td colspan="2">Non-dengue</td><td>OR(95%CI)</td></tr><tr><td> </td><td>N</td><td>%</td><td>N</td><td>%</td><td> </td></tr><tr><td>History:</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Exhaustion</td><td>68</td><td>98.6</td><td>69</td><t... | <table><tr><td>Clinical data</td><td colspan="2">Dengue</td><td colspan="2">Non-dengue</td><td>OR(95%CI)</td></tr><tr><td></td><td>N</td><td>%</td><td>N</td><td>%</td><td></td></tr><tr><td>History:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Exhaustion</td><td>68</td><td>98.6</td><td>69</td><td>95.8</... | <table><tr><td>Clinical data</td><td colspan="2">Dengue</td><td colspan="2">Non-dengue</td><td>OR(95%CI)</td></tr><tr><td></td><td>N</td><td>%</td><td>N</td><td>%</td><td></td></tr><tr><td>Chills</td><td>33</td><td>47.8</td><td>42</td><td>57.5</td><td></td></tr><tr><td>Dizziness</td><td>33</td><td>47.8</td><td>34</td><... |
bb5843917e41ab572c53e644028bd131793db90db1f14a940755889f7c4b097c.png | simple | <table><tr><td></td><td>Number</td><td>Age at diagnosis</td><td>Disease duration</td><td>Anti-CCP-positive</td><td>RF-positive</td></tr><tr><td></td><td></td><td>(years)</td><td>(years)</td><td>(%)</td><td>(%)</td></tr><tr><td>RA <1 year</td><td>144</td><td>54</td><td>0.8</td><td>70</td><td>68</td></tr><tr><td>RA &g... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>RA <1 year</td></tr><tr><td>RA >5 years</td></tr><tr><td>AS</td></tr><tr><td>PsA</td></tr><tr><td>SLE</td></tr><tr><td>SSC</td></tr><tr><td>Healthy</td></tr></table> | <table><tr><td>Number</td><td>Age at diagnosis</td><td>Disease duration</td><td>Anti-CCP-positive</td><td>RF-positive</td></tr><tr><td></td><td>(years)</td><td>(years)</td><td>(%)</td><td>(%)</td></tr><tr><td>144</td><td>54</td><td>0.8</td><td>70</td><td>68</td></tr><tr><td>59</td><td>48</td><td>11</td><td>87</td><td>7... |
1fcd65c82f7c0dbc9827527a1f82d706187bf2e2553f146c837465dc5e836b63.png | simple | <table><tr><td>Pathology</td><td>Human FXTAS</td><td>CGG knock-in mouse</td></tr><tr><td>CGG trinucleotide repeat length</td><td>55 to 199 CGG repeat length, repeat instability</td><td>70 to 300 CGG repeats, modest repeat instability</td></tr><tr><td>Elevated FMR1 mRNA expression</td><td>Increased 2- to 8-fold</td><td>... | <table><tr><td>Pathology</td><td>Human FXTAS</td><td>CGG knock-in mouse</td></tr><tr><td>CGG trinucleotide repeat length</td><td>55 to 199 CGG repeat length, repeat instability</td><td>70 to 300 CGG repeats, modest repeat instability</td></tr><tr><td>Elevated FMR1 mRNA expression</td><td>Increased 2- to 8-fold</td><td>... | <table><tr><td>Cognitive Impairments</td><td>Poor working memory, anxiety, depression, social phobia</td><td>Spatial memory deficits, altered anxiety-like behaviors</td></tr><tr><td>Intranuclear inclusions</td><td>Neurons and astrocytes, highly correlated with CGG repeat length, frequency increases with age</td><td>Neu... |
8ad6c83b2bc2d333600198de3ce3dc8e987489e6345c9fb97daf89ba9a795b4d.png | complex | <table><tr><td></td><td colspan="2">Any quantity fills</td><td colspan="2">Single bottle gills of 2.5 mL</td></tr><tr><td>Method of imputing days supply</td><td>Sensitivity</td><td>Specificity</td><td>Sensitivity</td><td>Specificity</td></tr><tr><td>Medication possession</td><td></td><td></td><td></td><td></td></tr><tr... | <table><tr><td></td><td colspan="2">Any quantity fills</td><td colspan="2">Single bottle gills of 2.5 mL</td></tr><tr><td>Method of imputing days supply</td><td>Sensitivity</td><td>Specificity</td><td>Sensitivity</td><td>Specificity</td></tr><tr><td>Medication possession</td><td></td><td></td><td></td><td></td></tr><tr... | <table><tr><td></td><td colspan="2">Any quantity fills</td><td colspan="2">Single bottle gills of 2.5 mL</td></tr><tr><td>Method of imputing days supply</td><td>Sensitivity</td><td>Specificity</td><td>Sensitivity</td><td>Specificity</td></tr><tr><td>Unadjusted days supply</td><td>53%</td><td>68%</td><td>43%</td><td>99%... |
b4268249ddcd4f47f75ee5f089e2f67cceb1fcb150cb9d144c5cddc2153afcf6.png | simple | <table><tr><td>Trial</td><td>Design</td><td>No. of Participants</td><td>Women %</td><td>Mean Age</td><td>Suppl. (Y)</td><td>Follow-up (Y)</td><td>BC, mg</td><td>Vit A μg</td><td>Vit C mg</td><td>Vit E mg</td><td>Selenium μg</td></tr><tr><td>AREDS [62] 2001</td><td>2x2</td><td>4757</td><td>56</td><td>68</td><t... | <table><tr><td>Trial</td><td>Design</td><td>No. of Participants</td><td>Women %</td><td>Mean Age</td><td>Suppl. (Y)</td><td>Follow-up (Y)</td><td>BC, mg</td><td>Vit A μg</td><td>Vit C mg</td><td>Vit E mg</td><td>Selenium μg</td></tr><tr><td>AREDS [62] 2001</td><td>2x2</td><td>4757</td><td>56</td><td>68</td><td>6.3</td>... | <table><tr><td>Lippman et al [88], 2008</td><td>2x2</td><td>35533</td><td>0</td><td>62</td><td>5.5</td><td>5.5</td><td></td><td></td><td></td><td>400</td><td>200</td></tr><tr><td>Liu et al [89], 2007</td><td>Parallel</td><td>763</td><td>68</td><td>85</td><td>1.6</td><td>1.6</td><td>16</td><td>400</td><td>80</td><td>44<... |
c2a4786ae85f1bd322d37e6da86a75e276d90473728e5ff5d05187c1516dc36f.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="5">Blood component</td></tr><tr><td>Plasma</td><td>P-PRP+NID</td><td>P-PRG</td><td>PPP+NID</td><td>PPG</td></tr><tr><td> </td><td><i>(n=40)</i></td><td><i>(n=40)</i></td><td><i>(n=40)</i></td><td><i>(n=40)</i></td><td><i>(n=40)</i></td></tr><tr><td>Total protein -TP-... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Blood component</td></tr><tr><td>Plasma</td><td>P-PRP+NID</td></tr><tr><td></td><td>(n=40)</td><td>(n=40)</td></tr><tr><td>Total protein -TP- (mg/mL)*</td><td>45.9 (4.4)a</td><td>49.5 (6.2)b</td></tr><tr><td>TGF-β1 (pg/mL)</td><td>1114.3 (457.7)c</td><td>3192.7 (1... | <table><tr><td colspan="3">Blood component</td></tr><tr><td>P-PRG</td><td>PPP+NID</td><td>PPG</td></tr><tr><td>(n=40)</td><td>(n=40)</td><td>(n=40)</td></tr><tr><td>46.1 (4.5)</td><td>46.4 (5.0)</td><td>45.5 (5.5)</td></tr><tr><td>2555.5 (1069.4)d</td><td>1714.3 (496.3)</td><td>1508.0 (445.9)</td></tr><tr><td>56.0 (24.... |
fd56fb8c62a46419cc47becdc99be03e661fbb67f6eec7f2479dfbe2bc4f1c34.png | simple | <table><tr><td>Haplotype</td><td>Case</td><td>Control</td><td>P-value</td></tr><tr><td>2-2-1-2-1-1</td><td>6.115</td><td>6.69</td><td>0.2675</td></tr><tr><td>2-2-1-2-1-2</td><td>0.9372</td><td>0</td><td>0.308</td></tr><tr><td>2-2-1-2-3-1</td><td>0.6905</td><td>0</td><td>0.9992</td></tr><tr><td>2-2-1-4-1-1</td><td>828.9... | <table><tr><td>Haplotype</td><td>Case</td><td>Control</td></tr><tr><td>2-2-1-2-1-1</td><td>6.115</td><td>6.69</td></tr><tr><td>2-2-1-2-1-2</td><td>0.9372</td><td>0</td></tr><tr><td>2-2-1-2-3-1</td><td>0.6905</td><td>0</td></tr><tr><td>2-2-1-4-1-1</td><td>828.9</td><td>834</td></tr><tr><td>2-2-1-4-1-2</td><td>9.433</td>... | <table><tr><td>P-value</td></tr><tr><td>0.2675</td></tr><tr><td>0.308</td></tr><tr><td>0.9992</td></tr><tr><td>0.8783</td></tr><tr><td>0.8322</td></tr><tr><td>3.747E-05</td></tr><tr><td>0.3188</td></tr><tr><td>0.3267</td></tr><tr><td>1</td></tr><tr><td>1</td></tr><tr><td>0.3793</td></tr><tr><td>0.7131</td></tr><tr><td>... |
90d7a0c213c7615915df19dcadb540d2efe614e2839a3f3b18464eaa833a1ed4.png | simple | <table><tr><td>Stage dose and route</td><td>Patients, <i>n </i>(active:placebo)</td></tr><tr><td>SAD stage dose, route (cohort)</td><td></td></tr><tr><td> 0.3 IV (A)</td><td>4:1</td></tr><tr><td> 1.0 IV (B)</td><td>4:1</td></tr><tr><td> 1.0 SC (C)</td><td>4:1</td></tr><tr><td> 3.0 IV (D)</td><td>4:1</td></tr><tr><td> 3... | <table><tr><td>Stage dose and route</td><td>Patients, n (active:placebo)</td></tr><tr><td>SAD stage dose, route (cohort)</td><td></td></tr><tr><td>0.3 IV (A)</td><td>4:1</td></tr><tr><td>1.0 IV (B)</td><td>4:1</td></tr><tr><td>1.0 SC (C)</td><td>4:1</td></tr><tr><td>3.0 IV (D)</td><td>4:1</td></tr><tr><td>3.0 SC (E)</t... | <table><tr><td>Stage dose and route</td><td>Patients, n (active:placebo)</td></tr><tr><td>MAD stage dose, route (cohort)</td><td></td></tr><tr><td>1.0 SC (G)</td><td>8:2</td></tr><tr><td>3.0 SC (H)</td><td>16:4</td></tr><tr><td>5.0 IV (I)</td><td>4:1</td></tr></table> |
2c504635b0d03f80f03978ef339ea19b9fd5dde813d55b2540c78e9d3212ca61.png | simple | <table><tr><td>Adsorption Concentration (mol/L)</td><td>10<sup>−3</sup></td><td>10<sup>−2</sup></td><td>10<sup>−1</sup></td></tr><tr><td>Absorbance</td><td>1.004</td><td>0.860</td><td>0.377</td></tr><tr><td>Drug concentration</td><td>0.125 × 10<sup>−3</sup></td><td>0.106 × 10<sup>ͨ... | <table><tr><td>Adsorption Concentration (mol/L)</td><td>10−3</td><td>10−2</td><td>10−1</td></tr><tr><td>Absorbance</td><td>1.004</td><td>0.860</td><td>0.377</td></tr><tr><td>Drug concentration</td><td>0.125 × 10−3</td><td>0.106 × 10−2</td><td>0.045 × 10−1</td></tr><tr><td>The remaining amount of R6G in 20 mL solution (... | <table><tr><td>The amount of the adsorbed drug (mg)</td><td>0.239</td><td>4.085</td><td>101.114</td></tr><tr><td>The amount of the adsorbed drug by 1.0 g particles (mg)</td><td>239.0</td><td>408.5</td><td>1011.1</td></tr></table> |
c47420b469d96f4b6692bef05015c80a2b0c67da845815054a7fccf1ebd04d2b.png | simple | <table><tr><td>DNA Binding Factor</td><td>No. of Bound Genes in the Genome</td><td>No. of Bound Genes in hESCs</td><td>No. of Bound POLR3G-Dependent Genes</td><td>Hypergeometric Test p Value</td><td>Adjusted p Value (Benjamini-Hochberg)</td></tr><tr><td>NANOG</td><td>25,071</td><td>1,668 (12.2%)</td><td>166 (16.3%)</td... | <table><tr><td>DNA Binding Factor</td><td>No. of Bound Genes in the Genome</td><td>No. of Bound Genes in hESCs</td><td>No. of Bound POLR3G-Dependent Genes</td><td>Hypergeometric Test p Value</td><td>Adjusted p Value (Benjamini-Hochberg)</td></tr></table> | <table><tr><td>NANOG</td><td>25,071</td><td>1,668 (12.2%)</td><td>166 (16.3%)</td><td>3.64 × 10−5</td><td>2.19 × 10−4</td></tr><tr><td>KLF4</td><td>3,793</td><td>1,116 (8.2%)</td><td>105 (10.3%)</td><td>4.55 × 10−4</td><td>1.36 × 10−3</td></tr><tr><td>SOX2</td><td>5,682</td><td>467 (3.4%)</td><td>49 (4.8%)</td><td>6.57... |
4c170e3fb69ef00628029e6ede5ae2147a26122d866ee0cadedefa4207a4bcf2.png | simple | <table><tr><td></td><td><i>M</i></td><td><i>SD</i></td><td>Range</td></tr><tr><td>Townsend disability score</td><td>2.4</td><td>1.38</td><td>0–4</td></tr><tr><td>Social resources (LSNS-6)</td><td>15.4</td><td>5.90</td><td>0–30</td></tr><tr><td>Cognitive impairment (MMSE)</td><td>26.9</td><td>3.02</td><td>8&... | <table><tr><td></td></tr><tr><td>Townsend disability score</td></tr><tr><td>Social resources (LSNS-6)</td></tr><tr><td>Cognitive impairment (MMSE)</td></tr><tr><td>Loneliness</td></tr></table> | <table><tr><td>M</td><td>SD</td><td>Range</td></tr><tr><td>2.4</td><td>1.38</td><td>0–4</td></tr><tr><td>15.4</td><td>5.90</td><td>0–30</td></tr><tr><td>26.9</td><td>3.02</td><td>8–30</td></tr><tr><td>1.0</td><td>1.18</td><td>0–6</td></tr></table> |
6a56624040a4f9654bd576a3e8cb8ac145ae4e6b130b44bbd99eb1d1c1f13254.png | simple | <table><tr><td></td><td></td><td>Livron 6 loci (without Pwalt_Te39)</td><td>Aouste 7 loci</td></tr><tr><td><i>N</i><sub>e</sub> - LDNe</td><td></td><td>892 (243 - Infinite)</td><td>-1470 (585 - Infinite)</td></tr><tr><td><i>N</i><sub>e</sub> - ONeSAMP</td><td>Run 1</td><td>186 (103-327)</td><td>533 (202-1995)</td></tr>... | <table><tr><td></td><td></td><td>Livron 6 loci (without Pwalt_Te39)</td><td>Aouste 7 loci</td></tr><tr><td>Ne - LDNe</td><td></td><td>892 (243 - Infinite)</td><td>-1470 (585 - Infinite)</td></tr></table> | <table><tr><td></td><td></td><td>Livron 6 loci (without Pwalt_Te39)</td><td>Aouste 7 loci</td></tr><tr><td>Ne - ONeSAMP</td><td>Run 1</td><td>186 (103-327)</td><td>533 (202-1995)</td></tr><tr><td></td><td>Run 2</td><td>182 (93-314)</td><td>1209 (434-5855)</td></tr><tr><td></td><td>Run 3</td><td>142 (83-260)</td><td>184... |
51560cbcd0a7afefc39ce9838570c78c4044736c904873c089a391ccd04fe0e3.png | simple | <table><tr><td></td><td>Overall</td><td>Monotherapy</td><td>Part of double combination therapy</td><td>Part of triple combination therapy</td></tr><tr><td>Amikacin</td><td>17.3</td><td>15.7</td><td>19.4</td><td>9.5</td></tr><tr><td>Meropenem</td><td>11.8</td><td>7.2</td><td>10.8</td><td>26.2</td></tr><tr><td>Piperacill... | <table><tr><td></td><td>Overall</td><td>Monotherapy</td><td>Part of double combination therapy</td><td>Part of triple combination therapy</td></tr><tr><td>Amikacin</td><td>17.3</td><td>15.7</td><td>19.4</td><td>9.5</td></tr><tr><td>Meropenem</td><td>11.8</td><td>7.2</td><td>10.8</td><td>26.2</td></tr><tr><td>Piperacill... | <table><tr><td></td><td>Overall</td><td>Monotherapy</td><td>Part of double combination therapy</td><td>Part of triple combination therapy</td></tr><tr><td>Gentamicin</td><td>9.2</td><td>3.6</td><td>13.1</td><td>0</td></tr><tr><td>Cefotaxime</td><td>5.8</td><td>15.7</td><td>3.2</td><td>0</td></tr><tr><td>Fluconazole</td... |
25db41320027c4316da1c2865283f754594834ef505d9b73799c0c2ef5fecc46.png | simple | <table><tr><td>Section</td><td>Number of infants with indicators for OPD</td><td>Frequency distribution (%)</td></tr><tr><td>A. Functioning of physiological subsystems?</td><td>2</td><td>10</td></tr><tr><td>B. State of alertness during feeding†</td><td>-</td><td>-</td></tr><tr><td>C. Stress cues during feeding</t... | <table><tr><td>Section</td><td>Number of infants with indicators for OPD</td><td>Frequency distribution (%)</td></tr><tr><td>A. Functioning of physiological subsystems?</td><td>2</td><td>10</td></tr><tr><td>B. State of alertness during feeding†</td><td>-</td><td>-</td></tr></table> | <table><tr><td>C. Stress cues during feeding</td><td>15</td><td>75</td></tr><tr><td>D. Movement and muscle tone screening</td><td>4</td><td>20</td></tr><tr><td>E. Oral peripheral examination</td><td>8</td><td>40</td></tr><tr><td>F. Clinical feeding and swallowing evaluation</td><td>14</td><td>70</td></tr><tr><td>Diagno... |
79abc9c8374bb04143b175c3e4b6f5e2217a8379a84ebbd4e5a093368521e739.png | complex | <table><tr><td rowspan="3">Day from onset of fever</td><td rowspan="3">Day of defervescence</td><td colspan="5">Total fluid intake in ml</td><td colspan="5">IV fluids in ml</td></tr><tr><td colspan="2">DHF group</td><td colspan="2">DF group</td><td rowspan="2">P value*</td><td colspan="2">DHF group</td><td colspan="2">... | <table><tr><td>Day from onset of fever</td><td>Day of defervescence</td><td colspan="5">Total fluid intake in ml</td><td colspan="5">IV fluids in ml</td></tr></table> | <table><tr><td rowspan="2">Day from onset of fever</td><td rowspan="2">Day of defervescence</td><td colspan="2">DHF group</td><td colspan="2">DF group</td><td rowspan="2">P value*</td><td colspan="2">DHF group</td><td colspan="2">DF group</td><td rowspan="2">P value*</td></tr><tr><td>Mean</td><td>SD</td><td>Mean</td><t... |
3a1221e95c03a4ff2131e1dc16cd0bf1c6b7e3fa2cbaa525f2ee1a77c73ff997.png | simple | <table><tr><td>Variables</td><td>Total n (%)</td><td>Boys n (%)</td><td>Girls n (%)</td></tr><tr><td>Alcohol use & bullying others</td><td>15 (2.2)</td><td>13 (4.0)</td><td>2 (0.6)</td></tr><tr><td>Alcohol use & sexual activity</td><td>12 (1.8)</td><td>11 (3.4)</td><td>1 (0.3)</td></tr><tr><td>Early sexual inte... | <table><tr><td>Variables</td></tr><tr><td>Alcohol use & bullying others</td></tr><tr><td>Alcohol use & sexual activity</td></tr><tr><td>Early sexual intercourse & sexual activity</td></tr><tr><td>Alcohol use & cigarette use</td></tr><tr><td>Sexual activity & bullying others</td></tr><tr><td>Tablets use & bullying other... | <table><tr><td>Total n (%)</td><td>Boys n (%)</td><td>Girls n (%)</td></tr><tr><td>15 (2.2)</td><td>13 (4.0)</td><td>2 (0.6)</td></tr><tr><td>12 (1.8)</td><td>11 (3.4)</td><td>1 (0.3)</td></tr><tr><td>10 (1.5)</td><td>6 (1.8)</td><td>4 (1.1)</td></tr><tr><td>9 (1.3)</td><td>4 (1.2)</td><td>5 (1.4)</td></tr><tr><td>4 (0... |
01cfbec5a210b0dd3f1f8d84467b8367421f2824f98fd323f9890ca7653d84c1.png | complex | <table><tr><td></td><td colspan="3">All</td><td colspan="4">Age 35-59 years</td><td colspan="5">Age 60-74 years</td></tr><tr><td></td><td colspan="3">eGFR (mL/min/1.73 m<sup>2</sup>) </td><td colspan="3">eGFR (mL/min/1.73 m<sup>2</sup>) </td><td></td><td colspan="3">eGFR (mL/min/1.73 m<sup>2</sup>) </td><td></td><td></... | <table><tr><td></td><td colspan="3">All</td><td colspan="4">Age 35-59 years</td><td colspan="5">Age 60-74 years</td></tr><tr><td></td><td colspan="3">eGFR (mL/min/1.73 m2)</td><td colspan="3">eGFR (mL/min/1.73 m2)</td><td></td><td colspan="3">eGFR (mL/min/1.73 m2)</td><td></td><td></td></tr><tr><td></td><td>Coeff.</td>... | <table><tr><td>Classicalriskfactorsadjusted</td><td>-0.0025</td><td>0.97</td><td>0.6829</td><td>0.0181</td><td>1.18</td><td>0.3290</td><td></td><td>-0.0178</td><td>0.81</td><td>0.0020</td><td></td><td></td></tr><tr><td>Incident cardiovascular disease</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><t... |
6aa25d675073ecb78628041dcdde162e2c693c83791798fe9bfb59b856c37d97.png | simple | <table><tr><td>Gene symbol</td><td>Gene full name</td><td>Fold regulation</td><td>p-value</td></tr><tr><td>TLR2</td><td>Toll-like receptor 2</td><td>−30.20</td><td>0.02</td></tr><tr><td>IL1A</td><td>Interleukin 1, alpha</td><td>−7.85</td><td>0.01</td></tr><tr><td>LTB</td><td>Lymphotoxin beta (TNF superfamil... | <table><tr><td>Gene symbol</td><td>Gene full name</td><td>Fold regulation</td><td>p-value</td></tr><tr><td>TLR2</td><td>Toll-like receptor 2</td><td>−30.20</td><td>0.02</td></tr><tr><td>IL1A</td><td>Interleukin 1, alpha</td><td>−7.85</td><td>0.01</td></tr><tr><td>LTB</td><td>Lymphotoxin beta (TNF superfamily, member 3)... | <table><tr><td>CCL7</td><td>Chemokine (C-C motif) ligand 7</td><td>−3.78</td><td>0.00</td></tr><tr><td>CXCL3</td><td>Chemokine (C-X-C motif) ligand 3</td><td>−3.66</td><td>0.02</td></tr><tr><td>CXCR2</td><td>Chemokine (C-X-C motif) receptor 2</td><td>−3.55</td><td>0.02</td></tr><tr><td>TLR1</td><td>Toll-like receptor 1... |
062762c1a8a4bb249b12824f0b7797de7ee77af37c6fb0767304bf202913e407.png | simple | <table><tr><td></td><td>Intervention N = 392</td><td>Comparison N = 394</td><td></td></tr><tr><td>Birth interval (months)</td><td></td><td></td><td></td></tr><tr><td>Mead (SD)</td><td>40.0 (30)</td><td>38.1 (26)</td><td>F 0.89, p 0.35; unequal variance in birth interval</td></tr><tr><td>Missing</td><td>(2)</td><td>(1)<... | <table><tr><td></td><td>Intervention N = 392</td><td>Comparison N = 394</td><td></td></tr><tr><td>Birth interval (months)</td><td></td><td></td><td></td></tr><tr><td>Mead (SD)</td><td>40.0 (30)</td><td>38.1 (26)</td><td>F 0.89, p 0.35; unequal variance in birth interval</td></tr><tr><td>Missing</td><td>(2)</td><td>(1)<... | <table><tr><td>1000–1499</td><td>3</td><td>0</td><td></td></tr><tr><td>1500–1999</td><td>7</td><td>2</td><td></td></tr><tr><td>2000–2499</td><td>9</td><td>12</td><td></td></tr><tr><td>All with birth weight (≥ 2,500 g</td><td>367</td><td>380</td><td></td></tr><tr><td>Missing data</td><td>(3)</td><td>(2)</td><td></td></t... |
b8e22c81c2f23c8ab1f4f534f288cfe626b3cea860c84aa1c119d845401435a7.png | simple | <table><tr><td>Plasmid</td><td>Description</td><td>Source</td></tr><tr><td>pRL446</td><td></td><td>Elhai and Wolk, 1988</td></tr><tr><td>pMD18T</td><td>TA cloning vector</td><td>TaKaRa clonetech</td></tr><tr><td>pMD18Tslr1670</td><td></td><td>This study</td></tr><tr><td>pMD18Tslr1670KmR</td><td>Construction Δ<i>sl... | <table><tr><td>Plasmid</td><td>Description</td></tr><tr><td>pRL446</td><td></td></tr><tr><td>pMD18T</td><td>TA cloning vector</td></tr><tr><td>pMD18Tslr1670</td><td></td></tr><tr><td>pMD18Tslr1670KmR</td><td>Construction Δslr1670</td></tr><tr><td>pXT323</td><td>Construction ΔglpK</td></tr></table> | <table><tr><td>Source</td></tr><tr><td>Elhai and Wolk, 1988</td></tr><tr><td>TaKaRa clonetech</td></tr><tr><td>This study</td></tr><tr><td>This study</td></tr><tr><td>This study</td></tr></table> |
c6400f4903d4b2f3240a01ff28567ab391744b70ad19a28ab93215dc5df5bda2.png | simple | <table><tr><td> </td><td>Number of patients (%)</td></tr><tr><td>Histology</td><td> </td></tr><tr><td>Non-small cell lung cancer</td><td>56 (88%)</td></tr><tr><td>Other</td><td>6 (9%)</td></tr><tr><td>No pathology</td><td>2 (3%)</td></tr><tr><td>Dose schedule</td><td> </td></tr><tr><td>6 Gy × 5 fractions</td><td>2... | <table><tr><td></td><td>Number of patients (%)</td></tr><tr><td>Histology</td><td></td></tr><tr><td>Non-small cell lung cancer</td><td>56 (88%)</td></tr><tr><td>Other</td><td>6 (9%)</td></tr><tr><td>No pathology</td><td>2 (3%)</td></tr><tr><td>Dose schedule</td><td></td></tr><tr><td>6 Gy × 5 fractions</td><td>2 (3%)</t... | <table><tr><td></td><td>Number of patients (%)</td></tr><tr><td>Medically inoperable</td><td>47 (73%)</td></tr><tr><td>Surgically incurable</td><td>10 (16%)</td></tr><tr><td>Location</td><td></td></tr><tr><td>Central</td><td>23 (36%</td></tr><tr><td>Peripheral</td><td>41 (64%)</td></tr></table> |
c9aab763bca2a4ea931575e771d8be4b48bb1ba52d9ef60217591b63d48fcfe5.png | simple | <table><tr><td></td><td>n</td><td>TAC M (SE)</td><td>Activity counts/min M (SE)</td><td>MVPA percentage M (SE)</td><td>Lifestyle percentage M (SE)</td><td>Light percentage M (SE)</td><td>Sedentary percentage M (SE)</td><td>Wear time M (SE)</td></tr><tr><td>High OA men</td><td>252</td><td>410,694 (10,303)</td><td>465.6 ... | <table><tr><td></td><td>n</td><td>TAC M (SE)</td><td>Activity counts/min M (SE)</td><td>MVPA percentage M (SE)</td><td>Lifestyle percentage M (SE)</td><td>Light percentage M (SE)</td><td>Sedentary percentage M (SE)</td><td>Wear time M (SE)</td></tr><tr><td>High OA men</td><td>252</td><td>410,694 (10,303)</td><td>465.6 ... | <table><tr><td></td><td>n</td><td>TAC M (SE)</td><td>Activity counts/min M (SE)</td><td>MVPA percentage M (SE)</td><td>Lifestyle percentage M (SE)</td><td>Light percentage M (SE)</td><td>Sedentary percentage M (SE)</td><td>Wear time M (SE)</td></tr><tr><td></td><td>37</td><td>06)</td><td>)</td><td>0.7)</td><td>)</td><t... |
5ac0004f9f01bdc70014600af5a19dde108e6da8f686e74c29434d1c9a2ae7ae.png | simple | <table><tr><td>Variable</td><td>ML score (95% CI)<sup>a</sup></td><td>MEWS (95% CI)<sup>b</sup></td><td>Difference (95% CI for difference)<sup>c</sup></td><td><i>P </i>value</td></tr><tr><td>Cardiac arrest within 72 hours after presentation</td><td></td><td></td><td></td><td></td></tr><tr><td> Area under ROC curve</td>... | <table><tr><td>Variable</td><td>ML score (95% CI)a</td><td>MEWS (95% CI)b</td><td>Difference (95% CI for difference)c</td><td>P value</td></tr><tr><td>Cardiac arrest within 72 hours after presentation</td><td></td><td></td><td></td><td></td></tr><tr><td>Ar</td><td>0.78</td><td>0.6</td><td>0.101 (0.006 to </td><td>0.037... | <table><tr><td>Variable</td><td>ML score (95% CI)a</td><td>MEWS (95% CI)b</td><td>Difference (95% CI for difference)c</td><td>P value</td></tr><tr><td>ea under ROC curve</td><td>1</td><td>80</td><td>0.197)</td><td></td></tr><tr><td>Sensitivity</td><td>81.4</td><td>74.4</td><td>7.0 (-11.1 to 21.9)</td><td>0.581</td></tr... |
75cd49f78e9f0d1eaffeefcb53de4c0feeb43fb641424020d3e785894c40e5e9.png | simple | <table><tr><td></td><td>Prospective cohort</td><td>Fixed effects (all)</td><td>Fixed effects (worked > 41 h)</td><td>Fixed effects (worked >48 h)</td></tr><tr><td>N</td><td>5910</td><td>18,221</td><td>5889</td><td>1631</td></tr><tr><td>Long working hours (>48 h)</td><td>1%</td><td>9%</td><td>28%</td><td>100%</... | <table><tr><td></td><td>Prospective cohort</td><td>Fixed effects (all)</td><td>Fixed effects (worked > 41 h)</td><td>Fixed effects (worked >48 h)</td></tr><tr><td>N</td><td>5910</td><td>18,221</td><td>5889</td><td>1631</td></tr><tr><td>Long working hours (>48 h)</td><td>1%</td><td>9%</td><td>28%</td><td>100%</td></tr><... | <table><tr><td></td><td>Prospective cohort</td><td>Fixed effects (all)</td><td>Fixed effects (worked > 41 h)</td><td>Fixed effects (worked >48 h)</td></tr><tr><td>male</td><td></td><td>71%</td><td>58%</td><td>43%</td></tr><tr><td>Temporary contract</td><td>16%</td><td>32%</td><td>38%</td><td>45%</td></tr><tr><td>Multip... |
0409cc40daa3004ab8fa857c746c84784a2488f9230fb9a1fb26b702ce9a209e.png | complex | <table><tr><td></td><td colspan="2">Dawn</td><td colspan="2">Michelle</td></tr><tr><td>State PCL-5 TRASC*</td><td>Pre</td><td>Post</td><td>Pre</td><td>Post</td></tr><tr><td>#1: Flashbacks of traumatic events</td><td>3</td><td>3</td><td>0</td><td>2</td></tr><tr><td>#2: Altered sense of time</td><td>3</td><td>3</td><td>0... | <table><tr><td></td><td>Dawn</td></tr><tr><td>State PCL-5 TRASC*</td><td>Pre</td></tr><tr><td>#1: Flashbacks of traumatic events</td><td>3</td></tr><tr><td>#2: Altered sense of time</td><td>3</td></tr><tr><td>#3: Marked loss of emotional feeling</td><td>2</td></tr><tr><td>#4: Feeling what you are experiencing is not re... | <table><tr><td>Dawn</td><td colspan="2">Michelle</td></tr><tr><td>Post</td><td>Pre</td><td>Post</td></tr><tr><td>3</td><td>0</td><td>2</td></tr><tr><td>3</td><td>0</td><td>0</td></tr><tr><td>4</td><td>0</td><td>0</td></tr><tr><td>3</td><td>0</td><td>0</td></tr><tr><td>2</td><td>0</td><td>0</td></tr><tr><td>2</td><td>0<... |
28fb4e913395efe92e366c432c3a236f20147e641f07fe399fe91ab4c094d3cb.png | simple | <table><tr><td>Antinuclear antibodies</td><td>P1</td><td>P2</td></tr><tr><td>Anti-nRNP/SM</td><td>3+, 2+, 2+</td><td>3+, 2+, 1+</td></tr><tr><td>Anti-SM</td><td>N, N, N</td><td>2+, 1+, N</td></tr><tr><td>Anti-SSA</td><td>3+, 3+, 3+</td><td>3+, 3+, 3+</td></tr><tr><td>Anti-RO-52</td><td>N, N, N</td><td>3+, 3+, 3+</td></... | <table><tr><td>Antinuclear antibodies</td><td>P1</td><td>P2</td></tr><tr><td>Anti-nRNP/SM</td><td>3+, 2+, 2+</td><td>3+, 2+, 1+</td></tr><tr><td>Anti-SM</td><td>N, N, N</td><td>2+, 1+, N</td></tr><tr><td>Anti-SSA</td><td>3+, 3+, 3+</td><td>3+, 3+, 3+</td></tr></table> | <table><tr><td>Antinuclear antibodies</td><td>P1</td><td>P2</td></tr><tr><td>Anti-RO-52</td><td>N, N, N</td><td>3+, 3+, 3+</td></tr><tr><td>Anti-SSB</td><td>N, N, N</td><td>1+, N, N</td></tr><tr><td>Anti-SCOL-70</td><td>N, N, N</td><td>N, N, N</td></tr><tr><td>Anti-JO-1</td><td>N, N, N</td><td>N, N, N</td></tr><tr><td>... |
038d34393a893bf2852abf72c2c7c713bfe9cb7e636e0943835ba6438bccbabe.png | complex | <table><tr><td><i>Question</i></td><td><i>Number</i></td><td><i>%</i></td></tr><tr><td colspan="3">Blood on your tooth brush during brushing may be a sign of:</td></tr><tr><td>1. Gum disease</td><td>57</td><td>95.0</td></tr><tr><td>2. Tooth decay</td><td>2</td><td>3.3</td></tr><tr><td>3. I don’t know</td><td>1</t... | <table><tr><td>Question</td><td>Number</td><td>%</td></tr><tr><td colspan="3">Blood on your tooth brush during brushing may be a sign of:</td></tr><tr><td>1. Gum disease</td><td>57</td><td>95.0</td></tr><tr><td>2. Tooth decay</td><td>2</td><td>3.3</td></tr><tr><td>3. I don’t know</td><td>1</td><td>1.7</td></tr><tr><td ... | <table><tr><td>Question</td><td>Number</td><td>%</td></tr><tr><td>1. Stop brushing</td><td>1</td><td>1.7</td></tr><tr><td>2. Stop brushing the area that is bleeding</td><td>4</td><td>6.7</td></tr><tr><td>3. Continue brushing</td><td>22</td><td>36.7</td></tr><tr><td>4. See a dentist</td><td>33</td><td>55.0</td></tr><tr>... |
e2180c698c3f69d81c25a96c8353f8f5c300a5a5cf99be8e9d669c1fcd19a5e9.png | complex | <table><tr><td>Group</td><td>Biopsy</td><td colspan="2">Reaction</td><td></td><td></td></tr><tr><td></td><td></td><td>0</td><td>I</td><td>II</td><td>III</td></tr><tr><td>Dercum</td><td>Painful abdomen (n = 41)</td><td>11 (27)</td><td>14 (34)</td><td>16 (39)</td><td>-</td></tr><tr><td></td><td>Painful knee (n = 47)</td>... | <table><tr><td>Group</td><td>Biopsy</td><td colspan="2">Reaction</td><td></td></tr><tr><td></td><td></td><td>0</td><td>I</td><td>II</td></tr><tr><td>Dercum</td><td>Painful abdomen (n = 41)</td><td>11 (27)</td><td>14 (34)</td><td>16 (39)</td></tr><tr><td></td><td>Painful knee (n = 47)</td><td>11 (23)</td><td>21 (45)</td... | <table><tr><td></td></tr><tr><td>III</td></tr><tr><td>-</td></tr><tr><td>1 (2)</td></tr><tr><td>-</td></tr><tr><td>2 (5)</td></tr><tr><td>2 (5)</td></tr><tr><td>-</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr></table> |
abd182839cef970ae013ee983a4b52e657acf0339e4caaaa741d1b8326ca3a7a.png | complex | <table><tr><td></td><td>Coiling [n (%)]</td><td>Clipping [n (%)]</td><td>P</td></tr><tr><td>Deteriorated</td><td>2 (10.5)</td><td>7 (38.9)</td><td rowspan="3">0.1900</td></tr><tr><td>Unchanged</td><td>4 (21.1)</td><td>2 (11.1)</td></tr><tr><td>Improved</td><td>13 (68.4)</td><td>9 (50.0)</td></tr></table> | <table><tr><td></td><td>Coiling [n (%)]</td><td>Clipping [n (%)]</td><td>P</td></tr></table> | <table><tr><td>Deteriorated</td><td>2 (10.5)</td><td>7 (38.9)</td><td rowspan="3">0.1900</td></tr><tr><td>Unchanged</td><td>4 (21.1)</td><td>2 (11.1)</td></tr><tr><td>Improved</td><td>13 (68.4)</td><td>9 (50.0)</td></tr></table> |
f087a4758953d46c070f6265c9264462ddc335d43dcfc9bd34673e9bc4da5306.png | complex | <table><tr><td rowspan="2"></td><td>Group 1</td><td>Group 2</td><td rowspan="2"><i>P</i> value</td></tr><tr><td>(<i>n</i> = 19)</td><td>(<i>n</i> = 7)</td></tr><tr><td>Age (years), mean ± SD</td><td>29.4 ± 10.8</td><td>26.6 ± 9.2</td><td>0.549<sup>a</sup></td></tr><tr><td>BMI (kg/m<sup>2</sup>), mean ... | <table><tr><td rowspan="2"></td><td>Group 1</td><td>Group 2</td><td rowspan="2">P value</td></tr><tr><td>(n = 19)</td><td>(n = 7)</td></tr><tr><td>Age (years), mean ± SD</td><td>29.4 ± 10.8</td><td>26.6 ± 9.2</td><td>0.549a</td></tr><tr><td>BMI (kg/m2), mean ± SD</td><td>20.5 ± 3.4</td><td>20.0 ± 2.1</td><td>0.693a</td... | <table><tr><td rowspan="2"></td><td>Group 1</td><td>Group 2</td><td rowspan="2">P value</td></tr><tr><td>(n = 19)</td><td>(n = 7)</td></tr><tr><td>-out</td><td>.5)</td><td>.6)</td><td></td></tr><tr><td>Depth (mm), mean ± SD</td><td>15.3 ± 3.9</td><td>15.9 ± 3.6</td><td>0.710a</td></tr><tr><td>Basal volume (mL), median ... |
3a248e3a3f261d358cfe5fb0ce32593cfd4b4d516f2bf034a91208398b8a85b2.png | complex | <table><tr><td>Study</td><td>Intact +ve/−ve</td><td>Circumcised +ve/−ve</td><td>Odds ratio</td><td>95% confidence interval</td><td>Exact odds ratio</td><td>Exact 95% confidence interval</td></tr><tr><td>Agot </td><td>207/237</td><td>184/210</td><td>1.00</td><td>0.76–1.31</td><td>0.9968</td><td>0.7525&... | <table><tr><td>Study</td><td>Intact +ve/−ve</td><td>Circumcised +ve/−ve</td><td>Odds ratio</td><td>95% confidence interval</td><td>Exact odds ratio</td><td>Exact 95% confidence interval</td></tr><tr><td>Agot</td><td>207/237</td><td>184/210</td><td>1.00</td><td>0.76–1.31</td><td>0.9968</td><td>0.7525–1.3206</td></tr><tr... | <table><tr><td>Study</td><td>Intact +ve/−ve</td><td>Circumcised +ve/−ve</td><td>Odds ratio</td><td>95% confidence interval</td><td>Exact odds ratio</td><td>Exact 95% confidence interval</td></tr><tr><td>Warner</td><td>2316/2849</td><td>14352/21054</td><td>1.19</td><td>1.12–1.26</td><td>1.1925</td><td>1.1239–1.2653</td>... |
9848f7f7316751ed566e44d69b84532a2ac6b89edcbd35dc7c57fead78b3f47e.png | simple | <table><tr><td>Patient</td><td>Tumor site</td><td>T stage</td><td>N stage</td><td>M stage</td></tr><tr><td><i>1</i></td><td><i>Oral cavity</i></td><td>1</td><td>0</td><td>0</td></tr><tr><td><i>2</i></td><td><i>Oral cavity</i></td><td>4a</td><td>2b</td><td>0</td></tr><tr><td><i>3</i></td><td><i>Oral cavity</i></td><td>4... | <table><tr><td>Patient</td><td>Tumor site</td><td>T stage</td><td>N stage</td></tr><tr><td>1</td><td>Oral cavity</td><td>1</td><td>0</td></tr><tr><td>2</td><td>Oral cavity</td><td>4a</td><td>2b</td></tr><tr><td>3</td><td>Oral cavity</td><td>4a</td><td>2c</td></tr><tr><td>4</td><td>Oropharynx</td><td>2</td><td>0</td></t... | <table><tr><td>M stage</td></tr><tr><td>0</td></tr><tr><td>0</td></tr><tr><td>0</td></tr><tr><td>0</td></tr><tr><td>0</td></tr><tr><td>0</td></tr><tr><td>0</td></tr><tr><td>0</td></tr><tr><td>1</td></tr><tr><td>0</td></tr></table> |
975de7af531b3124069d7c83e664140461a94ea4f34d4d1f02b8525a20f5298f.png | complex | <table><tr><td rowspan="2" colspan="2">Variable</td><td colspan="4">Idealistic Distortion</td><td rowspan="2">χ<sup>2</sup></td><td rowspan="2">p Value</td></tr><tr><td>Lown (%)</td><td>Averagen (%)</td><td>Highn (%)</td><td>Very Highn (%)</td></tr><tr><td rowspan="2">Place of Residence</td><td>Urban</td><td>3 (0.... | <table><tr><td rowspan="2" colspan="2">Variable</td><td colspan="2">Idealistic Distortion</td></tr><tr><td>Lown (%)</td><td>Averagen (%)</td></tr><tr><td rowspan="2">Place of Residence</td><td>Urban</td><td>3 (0.5)</td><td>189 (29.3)</td></tr><tr><td>Rural</td><td>13 (1.5)</td><td>243 (27.5)</td></tr><tr><td rowspan="2... | <table><tr><td colspan="2">Idealistic Distortion</td><td rowspan="2">χ2</td><td rowspan="2">p Value</td></tr><tr><td>Highn (%)</td><td>Very Highn (%)</td></tr><tr><td>318 (49.3)</td><td>135 (20.9)</td><td rowspan="2">5.314</td><td rowspan="2">0.105</td></tr><tr><td>420 (47.6)</td><td>207 (23.4)</td></tr><tr><td>113 (50... |
3fd0d907104eeca6050be386436302f73c482b9a3070b634ac32a6a21c027428.png | complex | <table><tr><td> </td><td><i>BMI</i></td><td colspan="2"><i>Associated UK 1990 centile</i><sup><i><sup>2</sup></i></sup></td></tr><tr><td> </td><td> </td><td><i>Boys</i></td><td><i>Girls</i></td></tr><tr><td colspan="4"><i>(a) Classify their children as currently overweight</i></td></tr><tr><td> 7 yearsb</td><td>23.1</t... | <table><tr><td></td><td>BMI</td><td colspan="2">Associated UK 1990 centile2</td></tr><tr><td></td><td></td><td>Boys</td><td>Girls</td></tr><tr><td colspan="4">(a) Classify their children as currently overweight</td></tr><tr><td>7 yearsb</td><td>23.1</td><td>99</td><td>99</td></tr><tr><td>12 years</td><td>24.4</td><td>9... | <table><tr><td></td><td></td><td></td><td></td></tr><tr><td colspan="4">(b) Express concern that their children will become overweight in the future</td></tr><tr><td>7 yearsb</td><td>17.1</td><td>81</td><td>75</td></tr><tr><td>12 years</td><td>20.3</td><td>88</td><td>79</td></tr><tr><td>15 years</td><td>24.1</td><td>94... |
b22cca56dead2742fa3e03f37a611da298d7d6014a310f4fe448c8214753bedc.png | simple | <table><tr><td></td><td>All groups (average)</td><td>≥ 9 years (average)</td><td>< 9 years (average)</td><td><i>P</i> value (<i>t</i> test)</td></tr><tr><td>Resource consumption</td><td></td><td></td><td></td><td></td></tr><tr><td>Hospitalized</td><td>158 (12.4%)</td><td>96 (10.7%)</td><td>62 (16.4%)</td><td><... | <table><tr><td></td><td>All groups (average)</td><td>≥ 9 years (average)</td><td>< 9 years (average)</td><td>P value (t test)</td></tr><tr><td>Resource consumption</td><td></td><td></td><td></td><td></td></tr><tr><td>Hospitalized</td><td>158 (12.4%)</td><td>96 (10.7%)</td><td>62 (16.4%)</td><td></td></tr><tr><td>Length... | <table><tr><td></td><td>All groups (average)</td><td>≥ 9 years (average)</td><td>< 9 years (average)</td><td>P value (t test)</td></tr><tr><td>School days missed</td><td>2.1</td><td>2.0</td><td>2.3</td><td></td></tr></table> |
c3baf3893f653e331f1ad379b0f7e4a3fdf073986ca41ae8f0c06864ddee6820.png | simple | <table><tr><td>Plasma characteristics</td><td>β coefficient (S.E.)</td><td><i>P</i>value</td></tr><tr><td>Neurocognitive impairment</td><td>−0.03 (0.16)</td><td>0.859</td></tr><tr><td>Gender, male</td><td>−0.48 (0.23)</td><td>0.042</td></tr><tr><td>Current CD4+ count, per 50 copies</td><td>−0.04 ... | <table><tr><td>Plasma characteristics</td><td>β coefficient (S.E.)</td><td>Pvalue</td></tr><tr><td>Neurocognitive impairment</td><td>−0.03 (0.16)</td><td>0.859</td></tr><tr><td>Gender, male</td><td>−0.48 (0.23)</td><td>0.042</td></tr><tr><td>Current CD4+ count, per 50 copies</td><td>−0.04 (0.02)</td><td>0.021</td></tr>... | <table><tr><td>Plasma characteristics</td><td>β coefficient (S.E.)</td><td>Pvalue</td></tr><tr><td>IL-10, per 10 units</td><td>0.18 (0.10)</td><td>0.061</td></tr></table> |
285a209dcbe92d2e1085b2dce4ce0705d10837736d1be86222eb368d369c5c5a.png | simple | <table><tr><td>Characteristics</td><td>n (%)</td></tr><tr><td>Symptom occurrence (%)</td><td></td></tr><tr><td> Mean (range)</td><td>61 (21-100)</td></tr><tr><td>Incubation time (hr)</td><td></td></tr><tr><td> Mean (range)</td><td>2 (1-15)</td></tr><tr><td>Clinical symptoms<sup>2</sup></td><td></td></tr><tr><td> Diarrh... | <table><tr><td>Characteristics</td><td>n (%)</td></tr><tr><td>Symptom occurrence (%)</td><td></td></tr><tr><td>Mean (range)</td><td>61 (21-100)</td></tr><tr><td>Incubation time (hr)</td><td></td></tr><tr><td>Mean (range)</td><td>2 (1-15)</td></tr><tr><td>Clinical symptoms2</td><td></td></tr><tr><td>Diarrhea</td><td>78 ... | <table><tr><td>Characteristics</td><td>n (%)</td></tr><tr><td>Headache</td><td>6 (6.0)</td></tr></table> |
dfecf56606ec3096d12e47602c0b2a9396e01bc1558f8dbd89c652aab46c738f.png | complex | <table><tr><td>Final clinical outcome</td><td>Number (%) of patients</td></tr><tr><td colspan="2">Favorable (44 hips)</td></tr><tr><td>Excellent</td><td>19 (32.8)</td></tr><tr><td>Good</td><td>25 (43.1)</td></tr><tr><td colspan="2">Unfavorable (14 hips)</td></tr><tr><td>Fair</td><td>4 (6.9)</td></tr><tr><td>Poor</td><t... | <table><tr><td>Final clinical outcome</td></tr><tr><td>Favorable (44 hips)</td></tr><tr><td>Excellent</td></tr><tr><td>Good</td></tr><tr><td>Unfavorable (14 hips)</td></tr><tr><td>Fair</td></tr><tr><td>Poor</td></tr><tr><td>Total</td></tr></table> | <table><tr><td>Number (%) of patients</td></tr><tr><td>Favorable (44 hips)</td></tr><tr><td>19 (32.8)</td></tr><tr><td>25 (43.1)</td></tr><tr><td>Unfavorable (14 hips)</td></tr><tr><td>4 (6.9)</td></tr><tr><td>10 (17.2)</td></tr><tr><td>58 (100)</td></tr></table> |
f46e84f97046f60b805fa2eb37280a5211c9c7165f12e3196099fbb09558f456.png | simple | <table><tr><td>Traits/gene transcripts</td><td><i>BTN1A1</i></td><td><i>SCD</i></td><td><i>LPL</i></td><td><i>GPAM</i></td><td><i>ACACA</i></td><td><i>LPIN</i></td></tr><tr><td>CMY60 (kg)</td><td>0.43</td><td>0.48</td><td>0.40</td><td>0.65*</td><td>0.22</td><td>0.19</td></tr><tr><td>TDMY (kg)</td><td>0.17</td><td>0.28<... | <table><tr><td>Traits/gene transcripts</td><td>BTN1A1</td><td>SCD</td><td>LPL</td><td>GPAM</td><td>ACACA</td><td>LPIN</td></tr></table> | <table><tr><td>CMY60 (kg)</td><td>0.43</td><td>0.48</td><td>0.40</td><td>0.65*</td><td>0.22</td><td>0.19</td></tr><tr><td>TDMY (kg)</td><td>0.17</td><td>0.28</td><td>0.16</td><td>0.36</td><td>0.13</td><td>0.12</td></tr><tr><td>FPCTDMY (kg)</td><td>0.20</td><td>0.32</td><td>0.26</td><td>0.47</td><td>0.21</td><td>0.19</t... |
31b37e33fd67e2d7e5f0a9da4066599084ee6f55058b12d112804d6fe4565d16.png | complex | <table><tr><td>Cropping pattern</td><td colspan="4">SGS</td><td colspan="4">NGS</td></tr><tr><td></td><td>HF</td><td>MF</td><td>LF</td><td>Mean</td><td>HF</td><td>MF</td><td>LF</td><td>Mean</td></tr><tr><td>MZ-CP within row</td><td>1.92</td><td>1.71</td><td>1.30</td><td>1.65</td><td>1.92</td><td>1.73</td><td>1.01</td><... | <table><tr><td>Cropping pattern</td><td colspan="4">SGS</td><td colspan="4">NGS</td></tr><tr><td></td><td>HF</td><td>MF</td><td>LF</td><td>Mean</td><td>HF</td><td>MF</td><td>LF</td><td>Mean</td></tr><tr><td>MZ-CP within row</td><td>1.92</td><td>1.71</td><td>1.30</td><td>1.65</td><td>1.92</td><td>1.73</td><td>1.01</td><... | <table><tr><td>rows</td><td>.27</td><td>13</td><td></td><td>2</td><td>1</td><td>1.20</td><td></td><td>1</td></tr><tr><td>Sole cowpea</td><td>2.84</td><td>2.52</td><td>1.37</td><td>2.24</td><td>2.73</td><td>1.82</td><td>1.15</td><td>1.90</td></tr><tr><td>Mean</td><td>1.89</td><td>1.67</td><td>1.16</td><td>1.57</td><td>1... |
84e89f24a215fd06e144a44c62157f9bc9b969a4d89b6fad89b06816895bfa80.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2">Disease</td><td rowspan="2">EC<sub>50</sub> (95% CI) [pM]</td><td rowspan="2">Max. spec. lysis [%]</td><td colspan="2">Antigen Density [molecules/cell]</td></tr><tr><td>CD19</td><td>CD33</td></tr><tr><td>B cell lines</td><td>SEM</td><td><i>Pre-B ALL</... | <table><tr><td></td><td></td><td>Disease</td><td>EC50 (95% CI) [pM]</td><td>Max. spec. lysis [%]</td><td colspan="2">Antigen Density [molecules/cell]</td></tr></table> | <table><tr><td></td><td></td><td>Disease</td><td>EC50 (95% CI) [pM]</td><td>Max. spec. lysis [%]</td><td>CD19</td><td>CD33</td></tr><tr><td>B cell lines</td><td>SEM</td><td>Pre-B ALL</td><td>12 (8 – 18)</td><td>58.7</td><td>50,000 ± 17,000</td><td>< 100</td></tr><tr><td></td><td>BV173</td><td>Pre-B ALL</td><td>3 (1 – 6... |
9a71d7f9d05d3c682d7d5852d9ec5608018ff1607ab875d8f5e6b4c9e4040fe0.png | simple | <table><tr><td>Variable</td><td>Value</td><td>Effect</td><td>S.E.</td><td><i>CI</i></td><td><i>95%</i></td></tr><tr><td>Mother's BMI</td><td>4 points increment</td><td>0.85</td><td>0.12</td><td>0.62</td><td>1.08</td></tr><tr><td>Age (Mother)</td><td>5 years increment</td><td>0.73</td><td>0.17</td><td>0.41</td><td>1.06<... | <table><tr><td>Variable</td><td>Value</td><td>Effect</td><td>S.E.</td><td>CI</td><td>95%</td></tr><tr><td>Mother's BMI</td><td>4 points increment</td><td>0.85</td><td>0.12</td><td>0.62</td><td>1.08</td></tr><tr><td>Age (Mother)</td><td>5 years increment</td><td>0.73</td><td>0.17</td><td>0.41</td><td>1.06</td></tr><tr><... | <table><tr><td></td><td>>2 hrs vs. 1-2 hrs</td><td>-0.26</td><td>0.29</td><td>-0.83</td><td>0.3</td></tr><tr><td>Municipality income (low vs. high)</td><td></td><td>1.82</td><td>0.28</td><td>1.26</td><td>2.37</td></tr></table> |
67c42a463ea471947a4b65649c39d44c41d9210e63827c882004d9a99cad3770.png | simple | <table><tr><td>Items</td><td>n (%)</td><td>Male (n = 32)</td><td>Female (n = 35)</td></tr><tr><td>Knowledge about worm infection:</td><td> </td><td> </td><td> </td></tr><tr><td>Heard about liver fluke <i>“san tap</i>” or “<i>pha yat bai mai nai tap</i>”</td><td>34 (50.7)</td><td>34.4</td><td>65.... | <table><tr><td>Items</td><td>n (%)</td><td>Male (n = 32)</td><td>Female (n = 35)</td></tr><tr><td>Knowledge about worm infection:</td><td></td><td></td><td></td></tr><tr><td>Heard about liver fluke “san tap” or “pha yat bai mai nai tap”</td><td>34 (50.7)</td><td>34.4</td><td>65.7</td></tr><tr><td>How to get infection w... | <table><tr><td>Eating raw fish dishes (Koi Pa, Lap Pa Nuew)</td><td>8 (11.9)</td><td>12.5</td><td>11.4</td></tr><tr><td>Heard about roundworm</td><td>52 (77.6)</td><td>84.4</td><td>71.4</td></tr><tr><td>How to get infection with roundworm:</td><td></td><td></td><td></td></tr><tr><td>It just occurs in our body</td><td>2... |
3700f744568a3c5d3ba55ab1326d76b5a545db4072f4a38fd0e06f9cbc15d3d7.png | simple | <table><tr><td></td><td>Intervention Mean(SE)</td><td>Control Mean(SE)</td><td>Estimated Intervention Effect Mean (95%CI)</td><td>p-value from GEE model</td></tr><tr><td>Pre-intervention mean score</td><td>7.71 (0.11)</td><td>7.48 (0.09)</td><td></td><td></td></tr><tr><td>Post-intervention mean score</td><td>3.63 (0.26... | <table><tr><td></td><td>Intervention Mean(SE)</td><td>Control Mean(SE)</td><td>Estimated Intervention Effect Mean (95%CI)</td><td>p-value from GEE model</td></tr><tr><td>Pre-intervention mean score</td><td>7.71 (0.11)</td><td>7.48 (0.09)</td><td></td><td></td></tr><tr><td>Post-intervention mean score</td><td>3.63 (0.26... | <table><tr><td>Pre-post difference adjusted for number of physician visits</td><td>4.10 (0.18)</td><td>3.25(0.27)</td><td>0.85 (0.21 ;1.48)</td><td>0.01</td></tr></table> |
d6032dd12109d0140ced072b2b704223cd381f04129c65ee96e612045758976c.png | complex | <table><tr><td rowspan="2">Predictors</td><td rowspan="2">OR</td><td rowspan="2"><i>P</i> value</td><td colspan="2">95% CI</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td>Right side operation</td><td>2.37</td><td><0.001</td><td>1.52</td><td>3.70</td></tr><tr><td>Male</td><td>2.66</td><td><0.001</td><td>1.65... | <table><tr><td rowspan="2">Predictors</td><td rowspan="2">OR</td><td rowspan="2">P value</td><td colspan="2">95% CI</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td>Right side operation</td><td>2.37</td><td><0.001</td><td>1.52</td><td>3.70</td></tr><tr><td>Male</td><td>2.66</td><td><0.001</td><td>1.65</td><td>4.28... | <table><tr><td rowspan="2">Predictors</td><td rowspan="2">OR</td><td rowspan="2">P value</td><td colspan="2">95% CI</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td>BMI < 25.5 kg/m2</td><td>1.72</td><td>0.02</td><td>1.08</td><td>2.75</td></tr></table> |
df7d8f22377d6cfb2a8c0e7b7dfe21d290ebbf06089458a4b9e4aefcb397e31b.png | simple | <table><tr><td>Reference</td><td>Author</td><td>Article </td><td>Published in journal</td><td>Year published</td><td><i>n</i>subjects</td><td><i>n</i>teeth</td><td>Study design</td></tr><tr><td>[6]</td><td>Pogrel et al.</td><td>“Coronectomy: a technique to protect the inferior alveolar nerve” </td><td>J Ora... | <table><tr><td>Reference</td></tr><tr><td>[6]</td></tr><tr><td>[7]</td></tr><tr><td>[8]</td></tr><tr><td>[9]</td></tr><tr><td>[10]</td></tr><tr><td>[11]</td></tr><tr><td>[12]</td></tr><tr><td>[13]</td></tr></table> | <table><tr><td>Author</td><td>Article</td><td>Published in journal</td><td>Year published</td><td>nsubjects</td><td>nteeth</td><td>Study design</td></tr><tr><td>Pogrel et al.</td><td>“Coronectomy: a technique to protect the inferior alveolar nerve”</td><td>J Oral Maxillofac Surg</td><td>2004</td><td>41</td><td>50</td><... |
c2621825237b012019ff91ba94b4beaddc1003d046fe956e4676a9f0c63be991.png | simple | <table><tr><td>Astaxanthin Content mg/g</td><td>C <sup>2</sup></td><td>G <sup>3</sup></td><td>F <sup>4</sup></td><td>E <sup>5</sup></td><td>U <sup>6</sup></td><td>R <sup>7</sup></td></tr><tr><td>0</td><td>4304.24 ± 177.48 <sup>a</sup></td><td>612.47 ± 95.0 <sup>a</sup></td><td>1027.15 ± 105.80 <sup>a</su... | <table><tr><td>Astaxanthin Content mg/g</td><td>C 2</td><td>G 3</td><td>F 4</td><td>E 5</td><td>U 6</td><td>R 7</td></tr><tr><td>0</td><td>4304.24 ± 177.48 a</td><td>612.47 ± 95.0 a</td><td>1027.15 ± 105.80 a</td><td>120.56 ± 14.02 a</td><td>182.17 ± 14.02 a</td><td>2361.89 ± 146.96 b</td></tr><tr><td>3</td><td>4413.37... | <table><tr><td>Astaxanthin Content mg/g</td><td>C 2</td><td>G 3</td><td>F 4</td><td>E 5</td><td>U 6</td><td>R 7</td></tr><tr><td>6</td><td>4315.56 ± 147.14 a</td><td>845.24 ± 125.24 a,b</td><td>1024.54 ± 86.78 a</td><td>155.73 ± 16.10 a</td><td>196.59 ± 16.10 a</td><td>2093.46 ± 170.37 a,b</td></tr><tr><td>9</td><td>45... |
ad15b8b2cdccc9d1edb9cbf629785aa864bfd0da248623cc8490edba41704766.png | simple | <table><tr><td>DEG_Set</td><td>Annotated</td><td>COG</td><td>GO</td><td>KEGG</td><td>KOG</td><td>Pfam</td><td>Swiss-Prot</td><td>eggNOG</td><td>Nr</td></tr><tr><td>FD1/FD2</td><td>1825</td><td>573</td><td>981</td><td>603</td><td>959</td><td>1355</td><td>1230</td><td>1676</td><td>1795</td></tr><tr><td>FD2/FD3</td><td>17... | <table><tr><td>DEG_Set</td><td>Annotated</td><td>COG</td><td>GO</td><td>KEGG</td><td>KOG</td><td>Pfam</td><td>Swiss-Prot</td><td>eggNOG</td><td>Nr</td></tr><tr><td>F</td><td></td><td>5</td><td>981</td><td></td><td>95</td><td></td><td>12</td><td>167</td><td>17</td></tr></table> | <table><tr><td>D1/FD2</td><td>1825</td><td>73</td><td></td><td>603</td><td>9</td><td>1355</td><td>30</td><td>6</td><td>95</td></tr><tr><td>FD2/FD3</td><td>1753</td><td>607</td><td>995</td><td>587</td><td>928</td><td>1369</td><td>1255</td><td>1638</td><td>1731</td></tr><tr><td>FD1/FD3</td><td>2658</td><td>741</td><td>14... |
a4caccb0d2aacff4a9b9f073360df1a21ccd863e1eef5deef36f9d7ce5d4583b.png | simple | <table><tr><td>Tear location</td><td>Autograft</td><td>Allograft</td></tr><tr><td>Near femoral attachment</td><td>14</td><td>2</td></tr><tr><td>Near tibial attachment</td><td>1</td><td>2</td></tr><tr><td>Mid-substance</td><td>1</td><td>4</td></tr><tr><td>Stretched</td><td>2</td><td>2</td></tr><tr><td>No graft seen</td>... | <table><tr><td>Tear location</td><td>Autograft</td><td>Allograft</td></tr><tr><td>Near femoral attachment</td><td>14</td><td>2</td></tr><tr><td>Near tibial attachment</td><td>1</td><td>2</td></tr><tr><td>Mid-substance</td><td>1</td><td>4</td></tr></table> | <table><tr><td>Tear location</td><td>Autograft</td><td>Allograft</td></tr><tr><td>Stretched</td><td>2</td><td>2</td></tr><tr><td>No graft seen</td><td>1</td><td>1</td></tr></table> |
4038fbeb2302a8f34a1f2cf33044656f80191ede880a947f60c7f59cc48894dc.png | simple | <table><tr><td></td><td>Possible answers</td></tr><tr><td>How often do you use wikipedia as an information source in general?</td><td></td></tr><tr><td></td><td>Never</td></tr><tr><td></td><td>1-5x/week</td></tr><tr><td></td><td>Daily</td></tr><tr><td></td><td>1-5x/month</td></tr><tr><td>How often do you use Wikipedia ... | <table><tr><td></td><td>Possible answers</td></tr><tr><td>How often do you use wikipedia as an information source in general?</td><td></td></tr><tr><td></td><td>Never</td></tr><tr><td></td><td>1-5x/week</td></tr><tr><td></td><td>Daily</td></tr><tr><td></td><td>1-5x/month</td></tr><tr><td>How often do you use Wikipedia ... | <table><tr><td></td><td>Possible answers</td></tr><tr><td></td><td>High number of revisions</td></tr><tr><td></td><td>Date of latest revision</td></tr><tr><td></td><td>I compare it to specific literature</td></tr><tr><td></td><td>I discuss the content with my colleagues/teachers</td></tr><tr><td></td><td>I do not draw ... |
241ffc94e90c41606faa5054580a910ed1db05483d4e93ae336dbbaee31e0587.png | simple | <table><tr><td>ODI item</td><td>No sick-leave for PGP</td><td>Sick-leave for PGP</td><td>E.S.</td><td><i>p</i></td></tr><tr><td>Pain intensity</td><td>2.30 (0.84)</td><td>2.33 (0.88)</td><td>0.039</td><td>=.954</td></tr><tr><td>Personal care</td><td>0.90 (1.11)</td><td>0.94 (1.14)</td><td>0.033</td><td>=.889</td></tr><... | <table><tr><td>ODI item</td><td>No sick-leave for PGP</td><td>Sick-leave for PGP</td><td>E.S.</td><td>p</td></tr><tr><td>Pain intensity</td><td>2.30 (0.84)</td><td>2.33 (0.88)</td><td>0.039</td><td>=.954</td></tr><tr><td>Personal care</td><td>0.90 (1.11)</td><td>0.94 (1.14)</td><td>0.033</td><td>=.889</td></tr><tr><td>... | <table><tr><td>ODI item</td><td>No sick-leave for PGP</td><td>Sick-leave for PGP</td><td>E.S.</td><td>p</td></tr><tr><td>Standing</td><td>1.50 (1.33)</td><td>2.00 (1.22)</td><td>0.392</td><td>=.031</td></tr><tr><td>Sleeping</td><td>1.12 (0.85)</td><td>1.48 (1.03)</td><td>0.379</td><td>=.113</td></tr><tr><td>Sex</td><td... |
9627ddceef97c345f127a7d327699294d55c939ddfb741105a8c71638b1aa37a.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Anda</td><td colspan="2">Sør‐Gjæslingan</td></tr><tr><td>Oceanic</td><td>Coastal</td><td>Oceanic</td><td>Coastal</td></tr><tr><td colspan="5">Habitat</td></tr><tr><td>Intrinsic</td><td>0.000</td><td colspan="2">0.929</td><td></td></tr><tr><td>Weather</td><... | <table><tr><td rowspan="2"></td><td colspan="2">Anda</td><td colspan="2">Sør‐Gjæslingan</td></tr><tr><td>Oceanic</td><td>Coastal</td><td>Oceanic</td><td>Coastal</td></tr><tr><td colspan="5">Habitat</td></tr></table> | <table><tr><td>Intrinsic</td><td>0.000</td><td colspan="2">0.929</td><td></td></tr><tr><td>Weather</td><td>1.000</td><td colspan="2">0.153</td><td></td></tr><tr><td>Time</td><td>1.000</td><td colspan="2">0.030</td><td></td></tr><tr><td colspan="5">Commuting</td></tr><tr><td>Intrinsic</td><td>0.998</td><td>0.669</td><td... |
797fbecc5171f71d662ae7d5c112ea54258c5e84b15852c35db66fb92b9dce7d.png | simple | <table><tr><td>Variable</td><td>Odds ratio</td><td>95%confidence interval</td></tr><tr><td>Guideline-recommended vancomycin dosing</td><td>0.91</td><td>0.53-1.56</td></tr><tr><td>Vancomycin duration > 15 days</td><td>3.65</td><td>2.16-6.17</td></tr><tr><td>Weight greater than 100 kilograms</td><td>2.08</td><td>1.18-... | <table><tr><td>Variable</td><td>Odds ratio</td></tr><tr><td>Guideline-recommended vancomycin dosing</td><td>0.91</td></tr><tr><td>Vancomycin duration > 15 days</td><td>3.65</td></tr><tr><td>Weight greater than 100 kilograms</td><td>2.08</td></tr><tr><td>Pitt Bacteremia Score of four or greater</td><td>3.80</td></tr><tr... | <table><tr><td>95%confidence interval</td></tr><tr><td>0.53-1.56</td></tr><tr><td>2.16-6.17</td></tr><tr><td>1.18-3.67</td></tr><tr><td>2.17-6.63</td></tr><tr><td>1.28-4.92</td></tr><tr><td>1.38-4.15</td></tr><tr><td>2.15-6.18</td></tr><tr><td>1.24-3.49</td></tr><tr><td>0.56-1.57</td></tr><tr><td>0.57-2.27</td></tr><tr... |
fe1238296b0ad3b9740cca22d6ad04dcbbc3d1901802aee9711dd8861c4a88ff.png | simple | <table><tr><td>GEO ID</td><td>Sample count (case:control)</td><td>Platform</td><td>Sample source</td><td>Tissue</td></tr><tr><td>GSE14359</td><td>18: 2</td><td>GPL96 [HG-U133A] Affymetrix Human Genome U133A Array</td><td>in vivo</td><td>Bone, lung</td></tr><tr><td>GSE16102</td><td>48: 6</td><td>GPL96 [HG-U133A] Affymet... | <table><tr><td>GEO ID</td><td>Sample count (case:control)</td><td>Platform</td><td>Sample source</td><td>Tissue</td></tr><tr><td>GSE14359</td><td>18: 2</td><td>GPL96 [HG-U133A] Affymetrix Human Genome U133A Array</td><td>in vivo</td><td>Bone, lung</td></tr><tr><td>GSE16102</td><td>48: 6</td><td>GPL96 [HG-U133A] Affymet... | <table><tr><td>GEO ID</td><td>Sample count (case:control)</td><td>Platform</td><td>Sample source</td><td>Tissue</td></tr><tr><td>GSE36001</td><td>19: 6</td><td>GPL6102 Illumina human-6 v2.0 expression beadchip</td><td>in vitro</td><td>Bone</td></tr><tr><td>GSE32964</td><td>35: 1</td><td>GPL6947 Illumina HumanHT-12 V3.0... |
bba88094d3a094e87525892799993c5fca80332a9db1d5696a14ea5f9de84518.png | simple | <table><tr><td>Gene</td><td>Primer sequences</td><td>Amplicon length</td><td>Annealing temperature</td></tr><tr><td>MBD-1</td><td>5' TCTGGTTGCCAAGGTCCAAA 3'5' ACATCCATCTTCCCTTCCCGA 3'</td><td>122bp</td><td>61°C</td></tr><tr><td>vimentin</td><td>5' TGGAAGAGAACTTTGCCGTTG 3'5' AAGGTGACGAGCCATTTCCTC 3'</td><td>101bp</... | <table><tr><td>Gene</td><td>Primer sequences</td><td>Amplicon length</td><td>Annealing temperature</td></tr><tr><td>MBD-1</td><td>5' TCTGGTTGCCAAGGTCCAAA 3'5' ACATCCATCTTCCCTTCCCGA 3'</td><td>122bp</td><td>61°C</td></tr><tr><td>vimentin</td><td>5' TGGAAGAGAACTTTGCCGTTG 3'5' AAGGTGACGAGCCATTTCCTC 3'</td><td>101bp</td><t... | <table><tr><td>Gene</td><td>Primer sequences</td><td>Amplicon length</td><td>Annealing temperature</td></tr><tr><td>GRP78</td><td>5' CACCAATGACCAGAATCGCCT 3'5' CAATGCGCTCCTTGAGCTTT 3'</td><td>101bp</td><td>60°C</td></tr></table> |
0611e08ff517dbced53634f61934c5cf4b72a3e5ffb084ceafc485f9358ff470.png | simple | <table><tr><td>Conjugate</td><td><i>N</i></td><td>F<sub>0</sub>, RFU</td><td>F<sub>enz</sub>, RFU</td><td>F<sub>max</sub></td></tr><tr><td>BSA-FITC<sub>(Voss et al.)</sub></td><td>25</td><td>-</td><td>-</td><td>3450</td></tr><tr><td>KLH-sCy5</td><td>380-750</td><td>6.25</td><td>1140</td><td>18100</td></tr><tr><td>BSA-s... | <table><tr><td>Conjugate</td><td>N</td><td>F0, RFU</td><td>Fenz, RFU</td><td>Fmax</td></tr><tr><td>BSA-FITC(Voss et al.)</td><td>25</td><td>-</td><td>-</td><td>3450</td></tr></table> | <table><tr><td>KLH-sCy5</td><td>380-750</td><td>6.25</td><td>1140</td><td>18100</td></tr><tr><td>BSA-sCy5</td><td>6.7</td><td>2.37</td><td>1680</td><td>70800</td></tr><tr><td>rhBChE-sCy5</td><td>30</td><td>6.17</td><td>1750</td><td>28300</td></tr><tr><td>BSA-sCy7</td><td>6.5</td><td>1.8</td><td>660</td><td>36500</td></... |
f6d5a7dcad5fc4461c08ed4038362c87304bce0bbc5fbd6a099ff6d66d15c992.png | complex | <table><tr><td rowspan="2">AE or laboratory abnormality</td><td colspan="4">n (%)</td></tr><tr><td>Grade 1/2</td><td>Grade 3</td><td>Grade 4</td><td>Any grade</td></tr><tr><td colspan="5">Non-hematologic AEs of any cause occurring in ≥ 15% of patients</td></tr><tr><td> Fatigue/asthenia</td><td>33 (55)</td><td>12 ... | <table><tr><td rowspan="2">AE or laboratory abnormality</td><td colspan="4">n (%)</td></tr><tr><td>Grade 1/2</td><td>Grade 3</td><td>Grade 4</td><td>Any grade</td></tr><tr><td colspan="5">Non-hematologic AEs of any cause occurring in ≥ 15% of patients</td></tr><tr><td>Fatigue/asthenia</td><td>33 (55)</td><td>12 (20)</t... | <table><tr><td>Hand–foot syndrome and related disorders</td><td>8 (13)</td><td>3 (5)</td><td>0</td><td>11 (18)</td></tr><tr><td>Pyrexia</td><td>11 (18)</td><td>0</td><td>0</td><td>11 (18)</td></tr><tr><td>Weight decreased</td><td>11 (18)</td><td>0</td><td>0</td><td>11 (18)</td></tr><tr><td>Constipation</td><td>10 (17)<... |
318bec218aa81a3c5de1ead3e7e08b934351f889a53926e3179656cdb6189581.png | complex | <table><tr><td>Topic</td><td>Sub-Topic</td><td>Positive Feedback</td></tr><tr><td rowspan="3">Usability </td><td>Utilization</td><td>“Both the motor and cognitive tasks were easy.”</td></tr><tr><td>Learning</td><td>“There was no problem in learning the use of the system.”</td></tr><tr><td>Pleasa... | <table><tr><td>Topic</td><td>Sub-Topic</td><td>Positive Feedback</td></tr><tr><td rowspan="3">Usabi</td><td>Utilization</td><td>“Both the motor and cognitive tasks were easy.”</td></tr><tr><td>Learning</td><td>“There was no problem in learning the use of the system.”</td></tr><tr><td>Pleasa</td><td></td></tr></table> | <table><tr><td>lity</td><td>ntness</td><td>“The 3D glass was not uncomfortable.”“The environment was beautiful.”“The cycle-ergometer was manageable.”</td></tr><tr><td rowspan="3">Sense of Presence</td><td>Spatial Presence</td><td>“The feeling was to be in the real park.”“I had the feeling of being suspended.” “The envi... |
eea0a6a4010d559c5608f9786768c2f9502c010b4fe65189b83ab5001b85c322.png | complex | <table><tr><td></td><td colspan="6">Outdoor exposure from 10 am-4 pm corrected for protective factors (years; fifths)</td></tr><tr><td></td><td>< 0.073*</td><td>0.073 – 0.190</td><td>0.191 – 0.428</td><td>0.429 – 0.800</td><td>> 0.800</td><td><i>Trend test (p-value)</i><sup>‡</sup></td></t... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>Pure nuclear (No. of cases = 100)</td></tr><tr><td>OR§</td></tr><tr><td>(95% CI)</td></tr><tr><td>Pure cortical (No. of cases = 40)</td></tr><tr><td>OR§</td></tr><tr><td>(95% CI)</td></tr><tr><td>Pure posterior (No. of cases = 62)</td></tr><tr><td>OR§</td></tr><tr><td>... | <table><tr><td colspan="6">Outdoor exposure from 10 am-4 pm corrected for protective factors (years; fifths)</td></tr><tr><td>< 0.073*</td><td>0.073 – 0.190</td><td>0.191 – 0.428</td><td>0.429 – 0.800</td><td>> 0.800</td><td>Trend test (p-value)‡</td></tr><tr><td>Pure nuclear (No. of cases = 100)</td><td></td><td></td>... |
cb4e8996aadad123b3b7f07239f68c582dae775a7f0b364186672b1e66ed468d.png | complex | <table><tr><td></td><td colspan="2">Boys (N = 3,256)</td><td colspan="2">Girls (N = 3,158)</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td></tr><tr><td> 9</td><td>476</td><td>14.6</td><td>482</td><td>15.3</td></tr><tr><td> 10</td><td>479</td><td>14.... | <table><tr><td></td><td colspan="2">Boys (N = 3,256)</td><td colspan="2">Girls (N = 3,158)</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td></tr><tr><td>9</td><td>476</td><td>14.6</td><td>482</td><td>15.3</td></tr><tr><td>10</td><td>479</td><td>14.7<... | <table><tr><td>Medium-high</td><td>914</td><td>28.6</td><td>886</td><td>28.6</td></tr><tr><td>High</td><td>742</td><td>23.2</td><td>748</td><td>24.1</td></tr><tr><td>Weight status*</td><td></td><td></td><td></td><td></td></tr><tr><td>Under/acceptable weight</td><td>2,899</td><td>89.0</td><td>2,778</td><td>88.0</td></tr... |
ad5643c0542aff4cf52200574b8246b6b20c7f147a4911f8029b4706c762aead.png | complex | <table><tr><td>Synthesis feature</td><td>Traditional systematic review</td><td>Critical interpretive synthesis</td></tr><tr><td>Research question</td><td>• A research question is developed a priori and is not changed during the course of the research study.</td><td>• A compass question is developed, which c... | <table><tr><td>Synthesis feature</td><td>Traditional systematic review</td><td>Critical interpretive synthesis</td></tr><tr><td>Research question</td><td>• A research question is developed a priori and is not changed during the course of the research study.</td><td>• A compass question is developed, which can evolve ov... | <table><tr><td>Synthesis feature</td><td>Traditional systematic review</td><td>Critical interpretive synthesis</td></tr><tr><td>Literature search</td><td>• Exhaustive literature search</td><td>• Exhaustive literature search but can purposively sample literature outside of original search parameters</td></tr><tr><td row... |
eceb22f5f731eac85b63313fe0c59afbf31f1d2e5a9674865bec6f982af39ff1.png | simple | <table><tr><td>Model for total tibial cartilage volume</td><td>r<sup>2</sup></td><td>p Value for Δ r<sup>2 </sup>compared with the specified model</td><td>ΔF with addition to the model (p value for ΔF is the same as for Δr<sup>2</sup>)</td></tr><tr><td>Bone area only (+)</td><td>0.14</td><td>< 0.... | <table><tr><td>Model for total tibial cartilage</td><td>r2</td><td>p Value for Δ r2 compared with the</td><td>ΔF with addition to the model (p value f</td></tr></table> | <table><tr><td> volume</td><td></td><td> specified model</td><td>or ΔF is the same as for Δr2)</td></tr><tr><td>Bone area only (+)</td><td>0.14</td><td>< 0.001</td><td>N/A</td></tr><tr><td>Bone area (+) age (-)</td><td>0.21</td><td>< 0.001 compared with bone area only</td><td>14.84</td></tr><tr><td>Bone area (+) age (-... |
52721d02e4796cc1d74bc6ad8897f3ac3dad3b21f5c16fcc1afcabaf6c82f8a1.png | simple | <table><tr><td></td><td>No COPD</td><td></td><td>COPD</td><td></td><td>COPD/CHF</td></tr><tr><td>Number of beneficiaries</td><td>1,319,680</td><td></td><td>245,958</td><td></td><td>118,617</td></tr><tr><td> As % of all beneficiaries</td><td>84.30%</td><td></td><td>15.70%</td><td></td><td>7.60%</td></tr><tr><td>Personal... | <table><tr><td></td><td>No COPD</td><td></td></tr><tr><td>Number of beneficiaries</td><td>1,319,680</td><td></td></tr><tr><td>As % of all beneficiaries</td><td>84.30%</td><td></td></tr><tr><td>Personal Characteristics</td><td></td><td></td></tr><tr><td>Females, %</td><td>59.70%</td><td></td></tr><tr><td>Age (yrs), mean... | <table><tr><td>COPD</td><td></td><td>COPD/CHF</td></tr><tr><td>245,958</td><td></td><td>118,617</td></tr><tr><td>15.70%</td><td></td><td>7.60%</td></tr><tr><td></td><td></td><td></td></tr><tr><td>54.50%</td><td></td><td>55.10%</td></tr><tr><td>77.4 (7.2)</td><td></td><td>78.9 (7.4)</td></tr><tr><td>14%</td><td></td><td... |
bdd19a33958b0f90da56868206791ba7afbe58f5f8700992f4015b74ceb44972.png | simple | <table><tr><td>Author</td><td>Cell line name</td><td>Species</td><td>Location</td></tr><tr><td>Hishikawa et al. [61]</td><td>SP cells</td><td>Mouse</td><td>Renal interstitial space</td></tr><tr><td>Challen et al. [62]</td><td>SP cells</td><td>Mouse</td><td>Proximal tubules</td></tr><tr><td>Inowa et al. [30]</td><td>SP ... | <table><tr><td>Author</td></tr><tr><td>Hishikawa et al. [61]</td></tr><tr><td>Challen et al. [62]</td></tr><tr><td>Inowa et al. [30]</td></tr><tr><td>Dekel et al. [33]</td></tr><tr><td>Gupta et al. [34]</td></tr><tr><td>Maeshima et al. [4, 35]</td></tr><tr><td>Oliver et al. [63]</td></tr><tr><td>Bussolati et al. [36, 3... | <table><tr><td>Cell line name</td><td>Species</td><td>Location</td></tr><tr><td>SP cells</td><td>Mouse</td><td>Renal interstitial space</td></tr><tr><td>SP cells</td><td>Mouse</td><td>Proximal tubules</td></tr><tr><td>SP cells</td><td>Human</td><td>Not identified</td></tr><tr><td>Sca1+ cells</td><td>Mouse</td><td>Nontu... |
c224ebef39a383279ee96911d72304a7854e51813d6d07e235af3c1dcd8fa05a.png | simple | <table><tr><td>Classification</td><td>Co-biased as <i>At</i></td><td>Biased as <i>At </i>and <i>Aa</i></td><td>Co-biased as <i>Aa</i></td></tr><tr><td>Occurrence</td><td>219</td><td>302</td><td>325</td></tr><tr><td>Expected</td><td>173.1</td><td>419.2</td><td>253.7</td></tr></table> | <table><tr><td>Classification</td><td>Co-biased as At</td><td>Biased as At and Aa</td><td>Co-biased as Aa</td></tr><tr><td>Occurrenc</td><td>21</td><td>302</td><td>3</td></tr></table> | <table><tr><td>e</td><td>9</td><td></td><td>25</td></tr><tr><td>Expected</td><td>173.1</td><td>419.2</td><td>253.7</td></tr></table> |
f7bea5f1ef69f59698d51e4e5dcd2445b2e9258005e35056cea966092e3be322.png | complex | <table><tr><td colspan="2">P300</td><td colspan="2">N400 & N100</td></tr><tr><td>Amplitude (X)/Latency (L)</td><td>BVS Score</td><td>Amplitude (X)/Latency (L)</td><td>BVS Score</td></tr><tr><td>X > μ −σ</td><td>5</td><td>X < μ + σ</td><td>5</td></tr><tr><td>L < μ + σ</td... | <table><tr><td colspan="2">P300</td><td colspan="2">N400 & N100</td></tr></table> | <table><tr><td>Amplitude (X)/Latency (L)</td><td>BVS Score</td><td>Amplitude (X)/Latency (L)</td><td>BVS Score</td></tr><tr><td>X > μ −σ</td><td>5</td><td>X < μ + σ</td><td>5</td></tr><tr><td>L < μ + σ</td><td></td><td>L < μ + σ</td><td></td></tr><tr><td>μ − 1.5σ < X < μ −σ</td><td>4</td><td>μ + 1.5σ > X > μ + σ</td><t... |
ceb46f8ae4ac3888a3a491f1051b7118d5714d32ef831c45fc513b9274819df1.png | simple | <table><tr><td>Formulation</td><td><i>n</i></td></tr><tr><td>Drug type</td><td></td></tr><tr><td> Caffeine</td><td>0.60</td></tr><tr><td> Acetaminophen</td><td>0.66</td></tr><tr><td> Theophylline</td><td>0.71</td></tr><tr><td> Salicylic acid</td><td>0.73</td></tr><tr><td> Indomethacin</td><td>0.98</td></tr><tr><td>Cros... | <table><tr><td>Formulation</td></tr><tr><td>Drug type</td></tr><tr><td>Caffeine</td></tr><tr><td>Acetaminophen</td></tr><tr><td>Theophylline</td></tr><tr><td>Salicylic acid</td></tr><tr><td>Indomethacin</td></tr><tr><td>Cross-linker</td></tr><tr><td>1:2</td></tr><tr><td>1:4</td></tr></table> | <table><tr><td>n</td></tr><tr><td></td></tr><tr><td>0.60</td></tr><tr><td>0.66</td></tr><tr><td>0.71</td></tr><tr><td>0.73</td></tr><tr><td>0.98</td></tr><tr><td></td></tr><tr><td>1.24</td></tr><tr><td>1.25</td></tr></table> |
3c97df5cf0531551c9647b18bf52c26342efed6a6f3947a9832d987a3fee6656.png | complex | <table><tr><td></td><td colspan="2"></td><td colspan="2"></td><td colspan="8">Genotype calling</td></tr><tr><td>Read</td><td colspan="2">Read mapping</td><td colspan="2">Reference TR mapping</td><td colspan="2">Unmodified TR</td><td colspan="3">Homozygous VNTR</td><td colspan="3">Heterozygous VNTR†</td></tr><tr><... | <table><tr><td></td><td colspan="2"></td><td colspan="2"></td><td colspan="8">Genotype calling</td></tr><tr><td>Read</td><td colspan="2">Read mapping</td><td colspan="2">Reference TR mapping</td><td colspan="2">Unmodified TR</td><td colspan="3">Homozygous VNTR</td><td colspan="3">Heterozygous VNTR†</td></tr><tr><td>Set... | <table><tr><td></td><td colspan="2"></td><td colspan="2"></td><td colspan="8">Genotype calling</td></tr><tr><td>Read</td><td colspan="2">Read mapping</td><td colspan="2">Reference TR mapping</td><td colspan="2">Unmodified TR</td><td colspan="3">Homozygous VNTR</td><td colspan="3">Heterozygous VNTR†</td></tr><tr><td>Set... |
730837b3c7eab7f604bc8457c5bb3908f04510b6ce59d624f1d18513c9af7978.png | complex | <table><tr><td></td><td colspan="5">Time point</td></tr><tr><td>Parameter (unit)</td><td>Baseline</td><td>BL 10 ml∙kg<sup>− 1</sup></td><td>BL 20 ml∙kg<sup>− 1</sup></td><td>BL 30 ml∙kg<sup>− 1</sup> (haemorrhagic shock)</td><td>Resuscitation</td></tr><tr><td>MAP (mmHg)</td><td>117 (... | <table><tr><td></td><td colspan="5">Time point</td></tr><tr><td>Parameter (unit)</td><td>Baseline</td><td>BL 10 ml∙kg− 1</td><td>BL 20 ml∙kg− 1</td><td>BL 30 ml∙kg− 1 (haemorrhagic shock)</td><td>Resuscitation</td></tr><tr><td>MAP (mmHg)</td><td>117 (108; 122)</td><td>80 (74; 98)</td><td>44 (37; 72)</td><td>33 (30; 38)... | <table><tr><td>Flow densityWF (%)</td><td>44.7 (40.3; 50.5)</td><td>44.1 (36.5; 49.7)</td><td>38.7 (22.2; 44.1)</td><td>34.5 (32.8; 40.4)*</td><td>46.9 (41.7; 50.7)#</td></tr><tr><td>Flow densityCentral (%)</td><td>45.2 (36.7; 48.6)</td><td>43.4 (34.3; 46.4)</td><td>39.2 (21.3; 42.2)§</td><td>32.5 (32.2; 40.0)§</td><td... |
80382facaa9a60f92de1046b4a8ee97a2956d0b75c4f84835036aebf782c1532.png | complex | <table><tr><td colspan="5">Electrochemical Aptasensors Applied for Food Safeguard</td></tr><tr><td>Analyte</td><td>Matrix</td><td>Method details</td><td>Linear range and LOD</td><td>Reference</td></tr><tr><td><i>Salmonella Typhimurium</i></td><td>Pork</td><td>EIS based on AuNPs and GO</td><td>2.4–2.4 × 10<su... | <table><tr><td colspan="5">Electrochemical Aptasensors Applied for Food Safeguard</td></tr><tr><td>Analyte</td><td>Matrix</td><td>Method details</td><td>Linear range and LOD</td><td>Reference</td></tr><tr><td>Salmonella Typhimurium</td><td>Pork</td><td>EIS based on AuNPs and GO</td><td>2.4–2.4 × 103 CFU/mL, 3 CFU/mL</t... | <table><tr><td>Ochratoxin A</td><td>cocoa beans</td><td>Anti-OTA-aptamer on SPCE, EIS</td><td>0.15–2.5 ng/mL, 0.15 ng/mL</td><td>[22]</td></tr><tr><td>Aflatoxin M1</td><td>Milk</td><td>Hexaethyleneglycol modified aptamers on SPE, EIS</td><td>2–150 ng/L, 1.15 ng/mL</td><td>[23]</td></tr><tr><td>Aflatoxin B1</td><td>Alco... |
683cea178fd03d1db416d9b3a863283f00c489c495f52f9558d2ac64e8bf2db6.png | complex | <table><tr><td>Item</td><td>Budget share</td><td>Expenditure</td><td colspan="3">Prices</td></tr><tr><td></td><td></td><td></td><td>Cigarettes</td><td>Alcohol</td><td>Betel nuts</td></tr><tr><td></td><td></td><td>1.0062</td><td>-0.6517</td><td><i>-0.2503</i></td><td><i>-0.1041</i></td></tr><tr><td>Cigarettes</td><td>0.... | <table><tr><td>Item</td><td>Budget share</td><td>Expenditure</td><td colspan="3">Prices</td></tr><tr><td></td><td></td><td></td><td>Cigarettes</td><td>Alcohol</td><td>Betel nuts</td></tr><tr><td></td><td></td><td>1.0062</td><td>-0.6517</td><td>-0.2503</td><td>-0.1041</td></tr><tr><td>Cigarettes</td><td>0.439</td><td></... | <table><tr><td></td><td></td><td>4578</td><td>0.4840</td><td></td><td>261</td></tr><tr><td>Betel nuts</td><td>0.160</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>(1.116)</td><td>(-0.857)</td><td>(-0.857)</td><td>(-2.481)**</td></tr></table> |
2c7791ff4aabc1b107e3704d0d29a3b6ffbdfd2e696f26d599a8c939770885ec.png | complex | <table><tr><td colspan="2">Demographic variables</td><td>N*</td><td>%</td><td colspan="2">Demographic variables</td><td>N*</td><td>%</td></tr><tr><td rowspan="2">Sex</td><td>Male</td><td>110</td><td>24.6</td><td rowspan="4">Age in years</td><td>21-30</td><td>92</td><td>20.6</td></tr><tr><td>Female</td><td>338</td><td>7... | <table><tr><td colspan="2">Demographic variables</td><td>N*</td><td>%</td><td colspan="2">Demographic variables</td><td>N*</td><td>%</td></tr><tr><td rowspan="2">Sex</td><td>Male</td><td>110</td><td>24.6</td><td rowspan="4">Age in years</td><td>21-30</td><td>92</td><td>20.6</td></tr><tr><td>Female</td><td>338</td><td>7... | <table><tr><td colspan="2">Demographic variables</td><td>N*</td><td>%</td><td colspan="2">Demographic variables</td><td>N*</td><td>%</td></tr><tr><td rowspan="2">Title</td><td>Junior</td><td>144</td><td>32.1</td><td rowspan="2">Educational background</td><td>College and above</td><td>171</td><td>38.2</td></tr><tr><td>N... |
beca684708eb080eee0b29656ef4a3092865bbeca3085a1d5d795a6583af70a2.png | simple | <table><tr><td></td><td>Open abdominal wall hernia repair</td><td>Laparoscopic abdominal wall hernia repair</td></tr><tr><td>Hematoma</td><td>6 %</td><td>1 %</td></tr><tr><td>Seroma</td><td>4 %</td><td>3 %</td></tr><tr><td>Visceral lesions</td><td>0</td><td>0</td></tr><tr><td>Sub-occlusion</td><td>0</td><td>0</td></tr>... | <table><tr><td></td><td>Open abdominal wall hernia repair</td><td>Laparoscopic abdominal wall hernia repair</td></tr><tr><td>Hematoma</td><td>6 %</td><td>1 %</td></tr><tr><td>Seroma</td><td>4 %</td><td>3 %</td></tr><tr><td>Visceral lesions</td><td>0</td><td>0</td></tr><tr><td>Sub-occlusion</td><td>0</td><td>0</td></tr>... | <table><tr><td>Infections of prosthesis</td><td>0</td><td>0</td></tr><tr><td>Fascial necrosis</td><td>0</td><td>0</td></tr><tr><td>Postop. Pain (6 mesi)</td><td>3 %</td><td>1 %</td></tr><tr><td>Recurrence</td><td>7 %</td><td>4 %</td></tr><tr><td>Mortality</td><td>0</td><td>0</td></tr></table> |
aca29999ed6637e5174654fb88981743e82d17502048b06f9f6d6e946f3f397b.png | complex | <table><tr><td></td><td colspan="4">Pearson Correlation (r) with Sleep Quality Scale (-)</td></tr><tr><td></td><td colspan="2">Study 1056</td><td colspan="2">Study 1077</td></tr><tr><td></td><td>r</td><td>p-value</td><td>r</td><td>p-value</td></tr><tr><td>Average Daily Diary Pain Numeric Rating Scale (-)</td><td>0.64</... | <table><tr><td></td><td colspan="4">Pearson Correlation (r) with Sleep Quality Scale (-)</td></tr><tr><td></td><td colspan="2">Study 1056</td><td colspan="2">Study 1077</td></tr><tr><td></td><td>r</td><td>p-value</td><td>r</td><td>p-value</td></tr><tr><td>Average Daily Diary Pain Numeric Rating Scale (-)</td><td>0.64</... | <table><tr><td>Quantity of Sleep (+)</td><td>-0.31</td><td><0.001</td><td>-0.34</td><td><0.001</td></tr><tr><td>Sleep Adequacy (+)</td><td>-0.21</td><td><0.001</td><td>-0.32</td><td><0.001</td></tr><tr><td>Somnolence (-)</td><td>0.11</td><td>0.004</td><td>0.15</td><td><0.001</td></tr></table> |
cdaef0d21c253142cdcaf8ac612fed4104682cf1fef783337f9cf40a52f3785b.png | simple | <table><tr><td>Isolate ID</td><td>Laccase (4<sup>th</sup>day)</td><td>Lipase (3<sup>rd</sup>day)</td><td>Cellulase (3<sup>rd</sup>day)</td><td>Source of isolation</td><td>Depth (m)</td></tr><tr><td>PKU F1</td><td>-</td><td>+</td><td>+</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F2</td><td>+</td><td>-</td><td>+</td>... | <table><tr><td>Isolate ID</td><td>Laccase (4thday)</td><td>Lipase (3rdday)</td><td>Cellulase (3rdday)</td><td>Source of isolation</td><td>Depth (m)</td></tr><tr><td>PKU F1</td><td>-</td><td>+</td><td>+</td><td>Seawater</td><td>0</td></tr></table> | <table><tr><td>PKU F2</td><td>+</td><td>-</td><td>+</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F3</td><td>+</td><td>++</td><td>++</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F4</td><td>++</td><td>+</td><td>+</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F5</td><td>-</td><td>++</td><td>-</td><td>Sediment</td>... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.